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1This work reports the production of recom-
binant yeast and viral proteins in a number
of diverse in vivo model systems for enzy-
matic and structural studies. In the first part
Hsp150 peptide, a derivative of the yeast
(Saccharomyces cerevisiae) secretory heat-
shock protein Hsp150, was investigated for
its ability to act as a carrier in transporting
the ectodomain of rat nerve growth factor
(NGFRe) out from the yeast cell. The
Hsp150-NGFRe fusion protein was effi-
ciently secreted into the growth medium,
where it constituted the majority of total
secreted proteins. Inhibition experiments with
purified Hsp150-NGFRe showed that
Hsp150 did not prevent NGFRe from fold-
ing into a ligand-binding conformation. Cir-
cular dichroism (CD) analysis revealed that
the Hsp150-carrier did not have any spe-
cific secondary structure, which was also sug-
gested by NMR analysis of a synthetic
polypeptide corresponding to the repetitive
consensus sequence of subunit II of Hsp150.
These findings suggest that Hsp150 can suc-
cessfully act as a carrier for foreign proteins,
such as NGFRe, made and secreted by S.
cerevisiae.
The second part of this study involved the
expression and purification of an RNA ani-
mal virus, Semliki Forest virus (SFV),
nonstructural proteins (Nsp1-4) using a  num-
ber of in vivo protein expression systems. To
ensure quantities large enough for structural
and enzymatic studies of the Nsps, each of
them was expressed either in bacteria (Es-
cherichia coli) or in insect cells (Sf9). All
the proteins were expressed in high quanti-
ties (10-100 mg/l), and purified by affinity
and size exclusion chromatography under
nondenaturing or denaturing conditions. In-
dependent of the expression system used, all
the partially purified Nsps aggregated and
precipitated either upon concentration, dialy-
sis, storing or thawing. No detergents were
found that could alleviate the aggregation
problem or assist in the purification process.
Despite the unsuccessful purification of
Nsps for structural studies, the expression and
partial purification of Nsp1 and Nsp3 permit-
ted biochemical characterization of their en-
zyme activities and posttranslational modifi-
cations. Point mutational analysis of the Nsp1
methyltransferase domain revealed that resi-
due His38 was essential for the guanylyl-
transferase activity of Nsp1. Furthermore,
residues Asp64 and Asp90 were found to be
important for the methyltransferase activity
of Nsp1. Phosphorylation sites in Nsp3 were
determinated by point mutational analysis,
electrospray ionization (ESI) and matrix as-
sisted laser desorption ionization (MALDI)
mass spectrometry (MS) as well as by
phosphopeptide mapping and Edman se-
quencing. A phosphorylated domain (aa 320-
368) was located in the C-terminal, non-con-
served region of Nsp3, where 12 serines and
4 threonines could be modified by phos-
phates. The phosphorylation of Nsp3 seemed
not to affect the membrane association or the
localization of Nsp3 in either transfected or
infected cells. Furthermore, Nsp3 phosphory-
lation deficient mutant viruses were capable
of replication in infected mammalian cells a
similar manner to the wild type SFV, but their
neuropathogenicity in adult mice was greatly
reduced.
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Molecular biology offers technologies
whereby proteins can be produced and puri-
fied easier and more efficiently than ever
before. Using recombinant DNA techniques
such as gene fusion it is possible to generate
chimeric proteins, which are novel in struc-
ture and function. At the DNA level, amino
acid coding regions are now routinely recom-
bined to incorporate new functional domains,
proteolytic cleavage sites, intra- and extra-
cellular localization or targeting signals,
stabilizing signals, and even amino acid
sequences that facilitate protein purification.
All of these directed mutations can be used to
subtly or dramatically alter the properties (e.g.,
solubility, electric charge, hydrophobicity,
conformation, substrate binding and active
sites) of the protein. Thus, protein engineer-
ing has become a powerful tool in molecular
biology to investigate protein structure and
function, in addition to production and purifi-
cation of useful proteins (Sassenfeld, 1990).
The main applications of recombinant proteins
obtained by genetic engineering are in the
medical therapeutic fields (e.g., production of
recombinant vaccines, and therapeutic proteins
for human diseases), and medical diagnosis
(e.g., antigen engineering for poly- and mono-
clonal antibody production used in disease
testing). Other areas where recombinant pro-
teins are commonly utilized include enzymes
for food and fiber production, testing food for
microbial contamination and veterinary medi-
cine (Nilsson et al., 1992).
Besides producing valuable proteins for
practical applications, the production of
proteins using recombinant technology offers
unprecedented possibilities in the basic
research of protein function, structure, inter-
action, turnover, domain shuffling, and many
other areas, which could ultimately lead to the
development of novel protein applications.
Most proteins are expressed in infinitesimal
amounts in their native cells and tissues, and
it is only by recombinant techniques that it is
possible to produce amounts great enough for
basic research or for practical uses. Therefore,
the expression of engineered proteins in effi-
cient heterologous protein expression system
is integral to the production, and purification
of many proteins of interest. Moreover, with
the vast amounts of predicted protein se-
quences being generated by genomic research,
the application of protein engineering will most
certainly be used to better characterize many
unknown protein functions, interactions,
cellular locations and potential practical uses.
1. PRODUCTION SYSTEMS FOR
RECOMBINANT PROTEINS
Although much of recombinant protein
engineering is performed in vitro, the actual
protein synthesis usually utilizes living
prokaryotic or eukaryotic cells. Proteins pro-
duced in vivo can be expressed transiently,
constitutively or by induction, with the last two
requiring cell lines which stably maintain the
genetic material coding for the protein.
Another means consist of using live bio-
reactors, i.e., live transgenic plants and
animals, as recombinant protein production
systems. The choice of production system
depends on many factors including the origi-
nal source of the protein and codon usage (e.g.,
prokaryotic, mammalian, plant), posttransla-
tional processing (e.g., phosphorylation, pro-
teolytic processing, glycosylation, acylation),
its future use (e.g., human therapy, plant pest
control) and economic factors (Hodgson,
1993). However, production of any protein is
a complex multistep cellular process involv-
ing gene transcription, translation, protein
processing and localization. Thus, the expres-
sion of a recombinant protein in a heterolo-
gous host cell or organism is often problem-
atic. For example, protein expression levels
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can be low, or the purified protein may be
insoluble or unstable. And although, certain
precautions can be taken (e.g., altering codon
usage to match the host’s cells), often trial and
error is the only real method of operation.
1.1. BACTERIAL EXPRESSION UTILIZING E. COLI
Escherichia coli (E. coli) has long been the
primary prokaryotic host for heterologous
protein expression, therefore there is much
information and technology regarding this
system with many different proteins (Baneyx,
1999; LaVallie et al., 1995). The advantages
of E. coli include its relatively easy, rapid and
inexpensive methods of growth, transforma-
tion and maintenance. Furthermore, most of
the biochemical pathways of E. coli are
understood in great detail, and its entire
genome has been sequenced. Foreign proteins
can be produced in E. coli in large amounts
(5-50% of total protein). Nevertheless,
prokaryotic cells such as E. coli are unable to
perform some posttranslational modifications,
which occur in eukaryotic cells (e.g., glyco-
sylation, phosphorylation and disulfidebond
formation), and which may be crucial for a
foreign protein to obtain an active form. The
expression and accumulation of a foreign pro-
tein in E. coli may also cause aggregates of
the protein to form (Lilie et al., 1998; De
Berbardez Clark, 1998). Sometimes the
protein in these inclusion bodies can be
refolded in vitro to produce functional protein,
but this is not always possible and renaturation
can be expensive and time consuming. Fur-
thermore, proteolytic degradation of heterolo-
gous protein expression may be a potential
obstacle (Murby et al., 1996; Matsuo et al.,
1999). Even though E. coli may not be useful
for all foreign protein production, it has been
successfully utilized to produce many func-
tional human proteins such as human growth
hormone, proinsulin, interferon-gamma and
antibody fragments (Patra et al., 2000; Cowley
and Mackin, 1997; Davis et al., 1999;
Plückthun, 1992).
1.1.1. Expression systems
Various E. coli expression systems are
available commercially and in the public
domain, which is shared within the scientific
community. Each system offers different
benefits for protein expression, detection, and
purification, and should be considered
according to the specific criteria and require-
ments each protein poses. The expression unit
or cassette in which the foreign protein coding
region will be cloned into should consist of a
strong promoter (e.g., T7, trc, lac, tac, PL, PR,
phoA, ara, xapA, cad, recA), ribosomal
binding site(s), and an efficient transcription
terminator (LaVallie et al., 1995). Tightly
controlled transcription coupled with a strong
and rapid transcription inducer (e.g., IPTG,
tryptophan, temperature, phosphatase starva-
tion, arabinose, xanthosine, pH, nalidixic acid)
are crucial for high protein expression. Other
factors to be considered include convenient
multiple cloning sites, appropriate codon
usage, and plasmid copy number. Usually, high
protein expression levels are desirable, but in
cases where the protein may form insoluble
inclusion bodies, or may be toxic to the bacte-
rial host, lower and slower expression may be
preferred. The ideal promoter for expression
directs efficient transcription to allow high-
level production, and is tightly regulated to
minimize the metabolic burden and toxic
effects of a foreign protein. Regulatable pro-
moters are used to drive foreign protein
expression to avoid the selection of non-
expressing mutant cells during the cell growth
phase. Promoters such as T3, SP6 and T7 are
widely used and efficient promoters derived
from E. coli bacteriophages.
The T7 RNA polymerase is very specific
for its own promoter, and can transcribe RNA
templates approximately five times faster than
the E. coli RNA polymerase (Mertens et al.,
1995). The gene coding for T7 RNA poly-
merase is either lysogenic or it is transfected
into the cell by the bacteriophage CE6. In DE3
E. coli cells the T7 RNA polymerase gene is
Introduction
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under the control of the LacUV5 promoter,
which is inducible by IPTG. The addition of
IPTG to a culture of DE3 cells will induce the
transcription of T7 RNA polymerase, which
in turn transcribes any gene under the control
of the T7 promoter. However, the basal level
of T7 RNA polymerase activity will promote
some transcription of the target gene in non-
induced cells. More strict control mechanisms
have been engineered to depress basal T7 RNA
polymerase expression. One method is based
on the addition of a regulatory lacI gene, which
codes for a strong repressor of the LacUV5
promoter (Dubendorff and Studier, 1991). Very
low basal expression levels of target gene can
be reduced even more by adding T7 lysozyme,
yet high level expression can be achieved upon
induction with IPTG. Moreover, the T7lacO
expression vectors pBAT, pHAT and pRAT
have been reported to be suitable for expres-
sion of toxic proteins in E. coli (Peränen et
al., 1996). In these vectors tight control is
achieved by centering the lac operator 14 base
pairs downstream from the major RNA tran-
scription start point.
1.1.2. Solubility
The majority of foreign proteins produced
in E. coli are cytosolic, but as mentioned above
some proteins accumulate as aggregates called
inclusion bodies. In these aggregates only a
small fraction of the protein is folded correctly,
and the rest is in a denatured and usually non-
functional form (Geisow, 1991; Valax and
Georgiou, 1993). The probability of any het-
erologous protein forming inclusion bodies
correlates greatly with its charge average and
turn forming residue fraction, whereas hydro-
philicity and total number of residues do not
appear to correlate with inclusion body for-
mation (Wilkinson and Harrison, 1991).
Inclusion bodies may consist of not only the
foreign protein, but also of some host compo-
nents such as T7 RNA polymerase, membrane
components, 16S and 23S RNA and even plas-
mid DNA (Mitraki and King, 1989). In some
cases the formation of inclusion bodies can be
advantageous, since the expressed protein can
be purified simply by washing and pelleting
the aggregated bodies (Georgiou and Valax,
1999). However, often the aggregation of the
protein is detrimental, therefore expression
conditions must be optimized so that the
possibility of producing soluble protein is
increased. The maximized solubility of a
protein can be achieved by optimizing several
factors such as the expression temperature, E.
coli strain used, pH of the growth medium,
fusion partner the protein is fused with, rate
and level of expression and co-expression with
chaperones and foldases (Murby et al., 1996;
Zhang et al., 1998; Weickert et al., 1996). For
example, fusions to ZZ (two domains derived
from staphylococcal protein A) and thio-
redoxin have been reported to increase the
solubility of insulin-like growth factor I and
cytokines (Samuelsson et al., 1994; LaVallie
et al., 1993). Chaperone proteins mediate both
the folding and rehabilitation of proteins (van
Dyk et al., 1989; Bukari and Zipser, 1973).
The most extensively studied chaperons/
foldases in E. coli are GroEL/GroES, which
have been reported to assist in folding proteins
into active forms (Goloubinoff et al., 1989;
Lee and Olins., 1992; Yasukawa et al., 1995;
Amrein et al., 1995; Wall and Plückthun,
1995). Moreover, co-overproduction of
thioredoxin has been reported to increase the
solubility of insulin-like growth factor I as well
as other vertebrate proteins expressed in E. coli
(Yasukawa et al., 1995). However, even if co-
overexpression of chaperons/foldases (e.g.,
GroES, GroEL, DnaK) is likely to be useful
for some proteins, it is unlikely to provide a
universal solution to the problem of inclusion
formation (Hockney, 1994). Other factors af-
fecting protein solubility include regulation of
the expression vector and bacterial cell lysis
methods. Protein inclusion bodies are usually
solubilized using urea or guanidine hydro-
cloride (Gdn-HCl). After denaturation the pro-
tein must be renatured under conditions that
favor their proper folding and native functions.
Conditions that must be considered when
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trying to refold a denatured protein involve
optimizing the renaturation temperature
(usually around 10°C), redox conditions,
protein concentration, and addition of solubi-
lizing additives such as polyethylene glycol.
Soluble and active proteins have also been
obtained with treatment with sarkosyl (N-
dodecanoyl-sarcosinate, Frangioni and Neel,
1992).
1.1.3. Secretion
Secretion of foreign proteins to the medium
can greatly facilitate their purification.
However, secretion of a protein to the medium
by Gram-negative bacteria, such as E. coli,
requires translocation of the protein through
the bacterial cell wall consisting of inner and
outer membrane bilayers surrounding the peri-
plasmic space. Only a limited number of E.
coli strains are capable of secreting proteins
from the cell (reviewed in Pugsley, 1993).
Nevertheless, some genetically modified
proteins with inserted secretion sequence sig-
nals, have been successfully secreted into the
media (Hgset et al., 1990; Wadensten et al.,
1991; Weiss et al., 1994; Samuelsson et al.,
1994). More importantly, E. coli is capable of
secreting genetically altered proteins into the
periplasm, which may represent 20-40% of the
total cellular volume. With this strategy the
target protein can be separated from the cyto-
plasmic proteins and accumulate in a more
oxidizing environment where disulfide-bond
formation can occur (Missiakas et al., 1993).
Secretion into the periplasmic space has been
successfully utilized in large scale production
of biologically active antibody fragments
(Plückthun, 1992).
1.2. YEAST (SACCHAROMYCES CEREVISIAE)
Saccharomyces cerevisiae (bakers and brew-
ers yeast) is generally considered as a safe or-
ganism for the production of foreign proteins,
since it has been used in food production for
thousands of years (Müller et al., 1998). This
unicellular eukaryote has been extensively
studied at the biochemical, molecular and
genomic levels, and its entire genome has been
recently sequenced (Goffeau et al., 1997). Like
E. coli, yeast grows rapidly in relatively in-
expensive and simple media, is easy to trans-
form, and maintain (Buckholz and Gleeson,
1991). But unlike E. coli, yeast is an eukaryotic
cell, and therefore expresses and processes pro-
teins more similarly to higher eukaryotes. (Lin
Cereghino and Cregg, 1999). The secretory
pathway of yeast closely resembles that of
mammalian cells, thus yeast is capable of many
posttranslational modifications such as pro-
teolytic processing, disulfide bond formation,
and glycosylation (Eckart and Bussineau,
1996). Thus, yeast offers a eukaryotic protein
production system that can retain the foreign
protein intracellularly or the product can be
secreted to the medium if fused to a carrier
peptide. However, S. cerevisiae is unable to
perform certain complex eukaryotic posttrans-
lational modifications such as prolylhydroxy-
lation and amidation. In addition, the glyco-
sylation of yeast can differ from that of higher
eukaryotes (Sudbery, 1996). Nevertheless,
many foreign proteins have been produced on
a large scale using S. cerevisiae, including
human serum albumin, the hepatitis B viral
surface antigen, insulin and hirudin (Goodly,
1993; Valenzuela et al., 1982; Thim et al.,
1986; Ladisch and Kohlmann, 1992; Mendoza-
Vega et al., 1994).
1.2.1. Episomal vectors and chromosomal
integration
Recombinant DNA which encodes foreign
proteins can be expressed in S. cerevisiae as
an episomal plasmid or integrated into its
genome. Extra-chromosomal replicons are
based either on plasmids containing auto-
nomously replicating sequences, or on the na-
tive 2µ circle of S. cerevisiae (Romanos et al.,
1992). Most yeast expression vectors have
been constructed from the multi-copy 2µ
plasmid, which has also been engineered to
replicate and be selectable in both E. coli and
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yeast. Because the native 2µ circle is present
in most S. cerevisiae strains at approximately
60-100 copies per haploid genome, and the
plasmid is stable inherited, 2µ-based protein
production can be very efficient (Futcher,
1988; Unternährer et al., 1991). The most com-
mon selection markers are LEU2, TRP1, URA3
and HIS3 in corresponding amino acid (aa)
uptake deficient mutant strains, which are
auxotrophic for leucine, tryphophan, uracil and
histidine, respectively. Selection can also be
performed using e.g., the antibiotic resistance
element G418, a 2-deoxy-streptamine antibi-
otic (Jimenez and Davies, 1980). There are
also yeast strains engineered to ensure plasmid
maintenance irrespective of the culture condi-
tions, for example, ura3 fur1 -strains are non-
viable on uracil minus media since they are
blocked both in the de novo and salvage path-
ways of uridine 5’-monophosphate synthesis
(Loison et al., 1986; Napp and Da Silva, 1993).
These strains can grow on uracil minus media
only if they maintain a plasmid that contains
the URA3 gene, which complements the
mutant allele.
Chromosomal integration offers a more
stable alternative to episomal maintenance of
plasmid DNA coding for foreign proteins. The
most widely utilized technique to obtain inte-
gration is homologous recombination (re-
viewed in Romanos et al., 1992). Integration
vectors are similar to the above mentioned
yeast plasmids with both E. coli and yeast
selectable markers and bacterial replication
sequences, but lack yeast replication se-
quences. Once the plasmid has been trans-
formed into a yeast cell, usually in a linear
form, it can not replicate, and is maintained
only if it integrates into the yeast genome.
Homologous recombination can occur by a
single or double crossover, either as a multi-
copy integration into ribosomal DNA, or by
transposable elements such as Ty or gamma
(Fleer, 1992). Double cross-over vectors con-
tain the foreign DNA and selection marker
flanked by yeast DNA homologues to the 5’
and 3’ regions of the chromosomal DNA to
be replaced. The frequency of transformation
by this method is lower than episomal plasmid
transformation, but it results in very stable,
usually single copy transformants (Romanos
et al., 1992). Multicopy integration of heter-
ologous genes usually employs integration into
reiterated chromosomal DNA sequences that
may be present from 20 to 140 repeats per
haploid genome. Chromosomal integration
can also be obtained by using Ty transposi-
tion vectors, which are analogous to the
retroviral vectors of mammalian cells (Boeke
et al., 1988).
1.2.2. Promoter strength
Many different yeast transcriptional promot-
ers are available for foreign protein expres-
sion in S. cerevisiae (Fleer 1992). Yeast
promoters consist of at least three elements
which regulate the efficiency and accuracy of
the initiation of mRNA transcription. These
elements are upstream activation sequences
(UAS), the TATA-box and initiator elements
(Romonos et al., 1992). Numerous strong
yeast promoters to be utilized are either in-
ducible (e.g., GAL1, GAL7, GAL10, MET25),
or constitutive (e.g., CYC1, ADH1, TEF2,
GPD and MF) (Mumberg et al., 1994 and
1995). In the case of large scale protein
production in yeast, it is crucial to be able to
separate the cell growth phase from the protein
production phase (Da Silva and Bailey, 1991).
The promoter strength of three different pro-
moters i.e., SUC2, PGK and GAL7 were stud-
ied when -amylase was produced in 30 hour
fed-batch yeast culture (Park et al., 1993).
According to the results the efficiency of the
promoters appeared to be in the following
order PGK> GAL7> SUC2, while plasmid
stability and promoter strength appeared to be
inversely correlated. Also expression vectors
with a tetracycline and copper ion regulatable
promoter systems have been developed (Gari
et al., 1997; Labbé and Thiele, 1999). Another
approach to optimize gene expression in yeast
utilizes transactivators such as mammalian
steroid hormone receptors, which have been
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reported to increase transcriptional activity
(Fleer, 1992), as well as regulate the overpro-
duction of the GAL4 protein (Schultz et al.,
1994).
1.2.3. Secretion of heterologous proteins
S. cerevisiae is capable of secreting heter-
ologous proteins, but most of them have to be
fused to an appropriate pre-pro-leader
(Romanos et al., 1992; Shuster, 1991). These
carriers are relatively short amino acid se-
quences and include pre-pro-leaders from such
proteins as -factor, killer-toxin, bar protease,
gp37, and Hsp150 (reviewed by Simonen,
1994). The carrier peptide may have a crucial
role in the transport process from the ER to
the Golgi, which has been suggested to be re-
ceptor- mediated (Balch et al., 1994). The car-
rier may thus provide a positive secretion sig-
nal for the capture of fusion protein into vesicle
budding sites at the ER membrane (Suntio et
al., 1999). The carrier may also assist the fu-
sion partner to acquire a secretion-competent
conformation (Simonen et al., 1994; Simonen
et al., 1996; Hammond and Helenius, 1995).
Some proteins can be externalized in S.
cerevisiae without a carrier. Human lipo-cor-
tin-1 was first expressed as a fusion with the
-factor pre-pro-region but only 10% of the
protein was secreted (Chung et al., 1996). An
expression system utilizing the inulinase sig-
nal peptide increased secreted lipocortin-1 5-
fold, resulting up to 95% of the protein to be
secreted into the medium (Chung et al., 1996).
Furthermore, fed-batch fermentation of the
heterologous protein produced 2.1 g/l, repre-
senting more than 80% of the total extracellu-
lar protein (Chung et al., 1999). Also, it has
been observed that culture growth conditions
can affect protein secretion (Rossini et al.,
1993). For example, ß-galactosidase, which is
normally refractile to secretion, is secreted
from yeast grown in a rich medium. ß-galac-
tosidase secretion could be further increased
by elevated growth temperatures.
1.2.3.1. Yeast secretory proteins as
carriers
In S. cerevisiae the most commonly used car-
rier is the pre-pro-region of the -factor (Fig.
1A and 1B). The pre-sequence (signal se-
quence) is cleaved upon translocation into the
ER and the pro-region is cleaved by the Kex2
protease in the Golgi compartment (Julius et
al., 1984). However, the mechanisms which
the -factor pre-pro-region uses to confer
Figure 1. A Schematic presentation of primary translation products of S. cerevisiae mating -factor
(A), pre-pro-region of -factor used as a carrier (B), killer toxin (C) and pre-pro-region of killer toxin
used as a carrier (D). Pre-pro-killer toxin carrier comprises killer toxin residues 1-34, which are joined
by alanine to the gamma-region residues 177-233. The Kex2 cleavage and N-glycosylation sites are
indicated by arrows and asterisks, respectively. The signal sequence is marked by a horizontally striped
area and the repetitive region of -factor is colored gray.
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secretion competence to the fusion partners,
as well as its structure, are not known. Syn-
thetic leaders have also been used as carriers
(Kjeldsen et al., 1997 and 1998b). Interest-
ingly, it appears that three N-linked oligosac-
charide chains are necessary for secretion com-
petence of the -factor pre-pro-leader, whereas
synthetic pre-pro-leaders lacking the consen-
sus N-glycosylation sites confers secretion
competence of correctly folded insulin precur-
sors (Kjeldsen et al., 1998a and 1998b).
Another polypeptide used as a carrier in
yeast is derived from the killer toxin (Fig. 1D).
The K1 killer toxin is a heterodimer of two
protein subunits ( and ß), maturated from the
316 residue pre-pro-toxin (Fig. 1C) (Bostian
et al., 1984). As in the pre-pro-region of -
factor, the signal sequence of the pre-pro-toxin
is cleaved upon translocation into the ER and
the pro-region is subsequently cleaved by the
Kex2 protease in the Golgi compartment
(Redding et al., 1991). The ability of different
fragments of the killer toxin pre-pro-region to
confer secretion competence for heterologous
protein was studied by fusing ß-lactamase to
various fragments of pre-pro-toxin (Cartwright
et al., 1992). The most efficiently secreted con-
struct had a carrier in which the genes of the
ß-subunit and the control region of  were
deleted (Fig. 1D). Secreted ß-lactamase
reached level of several µg/ml which is equal
to the level produced by the pre-pro-region of
the -factor (Cartwright et al., 1994).
1.2.3.2. The secretion pathway of S.
cerevisiae
The secretory pathway in eukaryotic cells
is essential for posttranslational processing,
targeting and transporting proteins to intra- and
extracellular membranes and for proteins des-
tined for export out of the cell. The secretory
pathway of yeast is depicted in Figure 2. It
consists of several membrane-bound compart-
ments and vesicle-trafficing systems between
these compartments. Protein secretion in yeast
has been studied using temperature-sensitive
secretion (sec) mutants, in which the transport
of proteins can be reversibly blocked in dis-
tinct compartments (Kaiser and Schekman,
1990). Secretery proteins have a signal pep-
tide, which is an endoplasmic reticulum (ER)
targeting sequence present usually at their N-
terminus, which allows the protein to enter the
ER. Most posttranslational modifications, such
as the initiation of glycosylation, disulfide
bond formation and protein folding occur in
the ER. Transport to the next compartment,
the cis Golgi, occurs by vesicular transport,
which is also the way proteins are transported
through the Golgi (intra-Golgi) to the trans
Golgi network (TGN) (Rexach and Sheckman,
1991). Transport, docking, and fusion of trans-
port vesicles are regulated by proteins gener-
ally refered to as SNAREs (reviewed by Gerst,
1999). The anterograde and/or retrograde
membrane traffic between the ER and Golgi
occurs in vesicles coated with COPI and COPII
proteins (Bednarek et al., 1995; Schekman and
Mellman, 1997; Orci et al., 1997). In the TGN
proteins are sorted into distinct vesicles, which
Figure 2. A schematic presentation of the secre-
tory route of yeast S. cerevisiae. The nascent
secretory proteins are translocated into the lumen
of the endoplasmic reticulum (ER), from where
they are transported by carrier vesicles via the
Golgi to the vacuole, the plasma membrane, the
cell wall or to the growth medium. Reproduction
from Saris (1998) with permission.
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are destined to the plasma membrane or to
vacuoles (Griffiths and Simons, 1986;
Conibear and Stevens, 2000). The sorting to
vacuoles occurs via a late endosome-like
prevacuolar compartment (Horazdovsky et al.,
1995; Gerrard et al., 2000; Götte and Lazar,
1999).
The ER signal sequence consists of a short
hydrophobic peptide with hydrophilic residues
at both ends (von Heijne, 1985; Rapoport et
al., 1996). Polypeptides are translocated into
the lumen of the ER usually cotranslationally,
although some proteins translocate post-
translationally. During co-translational trans-
location, the signal sequence of a nascent
polypeptide is first recognized by the signal
recognition particle (SRP) (Walter and
Johnson, 1994). After binding to the SRP,
translation is arrested until the complex is
bound to the ER membrane via the SRP
receptor. The translocation of proteins occurs
through translocation channels containing
hetero-trimeric complexes of the Sec61 protein
(Hanein et al.,1996; Hamman et al., 1997).
The signal peptides of proteins which trans-
locate posttranslationally are less hydrophobic
and are thus independent of SRP (Ng et al.,
1996; Rapoport et al., 1996). Posttranslational
translocation requires a complex of Sec62,
Sec63, Sec71 and Sec72 proteins in addition
to the Sec61p translocon channel (Panzner et
al., 1995; Brodsky and Scheckman, 1993). The
BiP chaperone has a critical role in trans-
location. It binds to the translocating poly-
peptide, acting as a molecular ratchet thus
preventing the backsliding of the protein
(Matlack et al., 1999).
The ER is the main location where secre-
tory proteins fold and it contains several
folding enzymes and chaperone proteins
essential for proper protein folding and trans-
port (Hong, 1996). The lumen of the ER is an
oxidizing environment and contains high
levels of calcium, which provides proper
conditions for chaperones and disulfide bond
formation (Lodish et al., 1992; Hwang et al.,
1992). Signal peptidase and glycosyl-
transferase complexes are functionally asso-
ciated, and signal sequence cleavage and
glycosylation, together with protein folding oc-
cur cotranslationally in the ER. In yeast cells,
proteins are glycosylated with N-linked and
O-linked glycans. Glycosylation is assumed
to promote correct folding, protect against
proteolysis and thermal denaturation, as well
as to regulate intracellular trafficking (Lis and
Sharon, 1993). In O-linked oligosaccharides,
the first mannose residue is attached to a serine
or threonine in the ER, which is unlike mam-
malian cells where mucin-type O-glyco-
sylation is initiated in the Golgi by adding an
N-acetyl-galactosamine to the fully folded
protein (Tanner and Lehle, 1987; Lussier et
al., 1995; Van den Steen et al., 1998). O-linked
oligosaccharide chains in yeast can be elon-
gated up to 5 mannoses in the Golgi (Fig. 3A)
whereas O-glycans in mammalian cells are
elongated by adding mannose, galactose, N-
acetyl glucosamine, fucose, sialylate residues
and/or polylactosamine-extensions (Varki,
1998, Van den Steen et al., 1998). N-glyco-
sylation of secreted glycoproteins in yeast is
initiated in the ER (Helenius, 1994, Helenius
et al., 1992). In yeast, the core oligosaccha-
ride consisting of two N-acetyl glucosamine,
nine mannose residues and three glucose resi-
dues is similar to that of higher eukaryotes (Fig.
3B) (Kukuruzinska et al., 1987). Unlike
mammalian cells, the mannose residues are not
replaced by other sugars (N-acetyl glu-
cosamine, galactose, fucose and sialic acid)
in the Golgi, but the outer chains are elongated
by mannose residues only (Fig. 3C) (Byrd et
al., 1982; Tanner and Lehle, 1987).
1.2.4. Optimizing expression
The genetic background of both natural and
recombinant yeast strains have been found to
affect the quantity and structure of heterolo-
gous proteins (Eckart and Bussineau, 1996).
Because different genetic backgrounds can
influence transcription and translation efficien-
cies, the secretory pathway, protein quality,
plasmid stability and plasmid copy number, it
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may be necessary to screen a number of
different host strains with varying genetic
backgrounds when optimizing heterologous
protein expression in yeast (Schultz et al.,
1994). Some genetic background consider-
ations that may aid in foreign protein produc-
tion in yeast include: the use of protease-
deficient strains, which can decrease heterolo-
gous protein degradation thus increasing yields
(Van den Hazel et al., 1996), and the use of
strains lacking hyperglycosylation of N-linked
sites (Schultz et al., 1994; Nakanishi-Shindo
et al., 1993). However, these strains usually
grow slower than normal strains, but there are
also yeast strains that require relatively few
generations to obtain high production yields
(Bussineau and Shuster, 1994). An N-termi-
nus sequence of human interleukin 1ß could
be utilized as an enhancer for heterologous
protein expression in the same way as has been
reported for two human growth hormones (Lee
et al., 1999). And, as in E. coli, the co-
expression of chaperones have been reported
to assist in the proper folding and secretion of
foreign proteins in S. cerevisiae (Langer et al.,
1992; Chen et al., 1994; Robinson et al., 1995).
Furthermore, the overexpression of disulfide
isomerase (PDI) resulted in a 10-fold increase
in secreted human platelet-derived growth
factor, a four fold increase in acid phosphatase
(Robinson et al., 1994), a two to eight fold
increase for five single chain antibody frag-
ments (Shusta et al., 1998), and a 15 to 24-
fold increase in antistasin (Schultz et al., 1994).
1.3. INSECT CELLS (BACULOVIRUS SYSTEM)
The baculovirus expression system (BVS)
is commonly used to express heterologous
proteins in insect cells (Kost and Condreay,
1999). Since insect cells are eukaryotic,
proteins expressed in them will be post-
translationally modified in a manner similar
to that of mammalian cells (Miller, 1988).
Insect cells can be grown as suspension cul-
tures, which permits the use of large-scale bio-
reactors for easier production scale-up. Fur-
thermore, unlike mammalian cell lines insects
cells do not require CO2-incubators. The most
commonly used baculovirus system utilized
Autographa californica Multiple Nuclear
Polyhedrosis virus (AcMNPV) (Jones and
Morikawa, 1996) in a cell line derived from
Lepidopteran Spodoptera frugiperda ovarian
cells (Sf9). The AcMNPV’s genome is a
double-stranded, circular DNA, approximately
130 kilobases in length, and has been fully
sequenced (Ayres et al., 1994). The produc-
Figure 3. Carbohydrate structures of S. cerevisiae
glycoproteins. (A) The first mannose of an O-
linked oligosaccharide is attached to a serine (Ser)
or threonine (Thr) residue in the ER and the chain
is elongated up to pentamannosides in the Golgi
compartment. (B) An N-acetyl glucosamine is
attached to an asparagine (Asp) residue to from
the core structure of N-linked oligosaccharide in
the ER and (C) the outer chains are elongated in
the Golgi. The length of the outer chain varies
from 2 to 15 mannose residues.
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tion systems are commonly regulated by strong
promoters like polyhedrin and p10 but also
immediate early promoters (for example ie1)
have been utilized (Jarvis et al., 1990). Latter
expression systems gave a continuous and
stable expression of human glycoprotein in
both infected and transformed Lepidopteran
cells (Jarvis et al., 1996).
As an alternative to baculovirus expression
systems, an expression cassette for continu-
ous protein expression by transformed insect
cells have also been developed (Farrell et al.,
1998). The system utilizes the promoter of the
silkmoth cytoplasmic actin gene, the ie1
transactivator gene and the HR3 enhancer re-
gion of Bombyx mori MNPV to stimulate gene
expression. Levels of produced proteins in this
system are comparable to the ones produced
in BVS (Lu et al., 1997; Keith et al., 1999).
1.3.1. Systems utilizing polyhedrin and
p10
In general, wild type baculoviruses exhibit
lytic and occluded life cycles, producing ex-
tra-cellular and occlusion derived virus
(ODV), respectively. ODV is embedded in
proteinaceous viral occlusions called poly-
hedra (Rohrmann, 1986). Polyhedrin, a 29 kD
protein, is the major component of polyhedra,
which in turn are crystalline occlusion bodies
visible in the nuclei of infected cells by light
microscopy. The expression of viral genes is
regulated in a successive cascade consisting
of 4 distinguishable phases: early, delayed
early, late and very late (Summers and Smith,
1988). During the very late phase of viral
replication two very abundant mRNAs are pro-
duced, one of which codes for the polyhedrin
protein and other codes for the p10 protein (10
kDa). The p10 polypeptide is involved in the
formation of fibrillar structures found both in
the nucleus and in the cytoplasm of baculo-
virus infected cells. The role of polyhedra is
to protect occluded baculoviruses after the
death of infected insects, and its presence is
essential for the maintenance of the virus in
nature. However, viral propagation in cell
cultures is based on virions which bud from
infected cells, not on ODV. Thus, baculovirus
expression vectors have been engineered in
which the polyhedrin and p10 coding regions
are deleted, but their strong promoters are re-
tained to express foreign proteins in large
amounts in the late and very late phases of
infection (Smith et al., 1983b; Kost and
Condreay, 1999).
In the baculovirus expression system utiliz-
ing the p10 promoter, the sequence encoding
the p10 protein as well as the entire polyhedrin
locus, including its promoter, have been
deleted (Vlak et al., 1990; Roelvink et al.,
1992; Bonning et al., 1994; Naggie and
Bentley, 1998). The remaining p10 promoter
is used to express recombinant protein se-
quences. In this way, expression of both the
native polyhedrin and p10 proteins are abol-
ished, which reduces background problems
caused by the expression of large amounts of
very late native proteins while increasing the
expression of foreign recombinant proteins.
Furthermore, the p10 promoter is activated
earlier in the infection cycle than the poly-
hedrin promoter (Roelvink et al., 1992;
Bonning et al., 1994). The absence of the p10
protein results in delayed cell lysis, and thereby
an extended period of recombinant protein syn-
thesis. The yields of two reporter enzymes, ju-
venile hormone esterase and ß-galactosidase
were higher under the p10 promoter compared
to polyhedrin controlled expression (Bonning
et al., 1994).
1.3.2. Recombination
In baculovirus expression systems the inser-
tion of genes coding for foreign proteins can
be accomplished by homologous recombina-
tion, site-specific transposition (Bac-to-Bac)
or insertion directly into the viral genome in
vitro. In homologous recombination, the gene
of interest is cloned into a transfer vector
containing a baculovirus promoter flanked by
baculovirus DNA derived from the polyhedrin
gene. After transfection into insect cells, the
gene is inserted into the genome of the parent
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virus by homologous recombination, at a rate
of approximately 0.1 to 1% (Smith et al.,
1983a). Recombinants are identified by their
altered plaque morphology, which appears as
‘occlusion minus’ plaques. A higher rate of
recombination can be achieved when the par-
ent virus genome is linearized at site(s) near
the target site of foreign gene insertion (Kitts
et al., 1990). Kitts and Possee (1993) reported
recombination rates approaching 100% when
they used linearized viral DNA that is miss-
ing an essential portion of the baculovirus ge-
nome downstream from the polyhedrin locus.
Nevertheless, by this method it can take more
than a month to purify the plaques, and con-
firm the desired recombinants. A faster method
to generate recombinant baculovirus can be
achieved by utilizing baculovirus Ac-omega,
which contains an unique restriction site down-
stream of the polyhedrin promoter (Ernst et
al., 1994). By this method recombinant viruses
were obtained 8 days posttransfection and
according to PCR analysis the non-recombi-
nant background was 25 fold lower than that
of the recombinant viral DNA. Another
method utilizing site-specific transposition is
also relatively fast (7 - 10 days) because plaque
purification or virus amplification are not
needed (Luckow et al., 1993). In this method,
the foreign gene is cloned into a baculovirus
shuttle vector (bacmid) that can replicate in E.
coli, but can also infect susceptible lepi-
dopteran insect cells (Fig. 4). Bacmid is a re-
combinant virus that contains a mini-F repli-
con, a kanamycin resistance marker, and
attTn7, the target site for the bacterial
transposon Tn7 (Leusch et al., 1995). Expres-
sion cassettes comprising a baculovirus
promoter driving expression of a foreign gene
that is flanked by the left and right ends of
Tn7, can transpose to the target bacmid in E.
coli when Tn7 transposition functions are pro-
vided by a helper plasmid.
1.3.3. Optimizing expression
The density at which cells are infected, and
the multiplicity of infection (m.o.i.) greatly
affects the expression of heterologous proteins
(Power et al., 1994; Licari and Bailey, 1992;
Wong et al., 1995; Klaassen et al., 1999). For
instance, when the integral membrane protein
bovine rhodpsin was expressed in large
amounts, the highest volumetric yields were
obtained with an m.o.i. of 0.01 during early to
mid-exponential growth (Klaassen et al.,
Figure 4. Schematic outline of the generation of
recombinant baculovirus with a bac-to-bac expres-
sion system. A donor vector carrying the gene of
interest flanked by a Tn7-element is transformed
to E. coli. The Tn7 element can integrate into the
attTn7 target site in the presence of transposition
proteins provided by a helper plasmid. Recombi-
nant bacmids are selected using their antibiotic
resistance and recombinant bacmid DNA is used
to transfect insect cells.
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1999). For easier purification, and cost saving
reasons, it is possible to produce heterologous
proteins in Sf9 cells in serum-free and pro-
tein-free media. The cells were gradually
adapted to serum-free media in monolayer
cultures and reached a doubling time of
approximately 25 h, compared with 18 h in
serum containing medium. Furthermore, the
control of proteolysis in insect cells has a im-
portant role when optimizing the yield of
recombinant protein (Naggie and Bentley,
1998). Like in S. cerevisiae, unwanted man-
nose residues can be added to secreted glyco-
proteins and they lack penultimate galactose
as well as terminal sialic acid residues (Jarvis
and Finn, 1996). The immediate early
promoters (for example ie1), have been shown
to be beneficial for protein production e.g.,
when highly glycosylated or otherwise modi-
fied proteins are to be produced (Bonning et
al., 1994; Chazenbalk and Rapoport, 1995).
1.4. MAMMALIAN EXPRESSION SYSTEMS
UTILIZING VACCINIA AND ALPHAVIRUS
VECTORS
In some cases, mammalian cell systems are
the only possible way to produce properly pro-
cessed and active foreign proteins. Gene trans-
fer into mammalian cells may be performed
either by infection with a virus carrying the
recombinant gene of interest (reviewed by
Makrides, 1999) or by direct transfer of plas-
mid DNA (Geisse and Kocher, 1999).
1.4.1. Vaccinia virus vector
Recombinant vaccinia virus vectors have
generally been acknowledged as versatile tools
for the expression of foreign genes (reviewed
by Moss, 1996). Since vaccinia is infectious
to man, safety aspects must be taken into con-
sideration, especially when working with
large-scale preparations. To circumvent safety
problems, an avian host-restricted vaccinia,
modified vaccinia Ankara (MVA), can be used
(Sutter et al., 1994; Wyatt et al., 1995). Fur-
thermore, MVA does not produce the rapid
cytophatic effect accompanied by destruction
of the cell monolayer seen with the standard
replication strains of vaccinia used. MVA has
been shown to efficiently produce foreign
proteins in several mammalian cell lines using
either the homologous vaccinia promoter, p11
(Sutter and Moss, 1992) or a hybrid vaccinia/
bacteriophage T7 promoter system (Wyatt et
al., 1995). In the vaccinia/T7 polymerase hy-
brid system, the vaccinia virus contains the T7
RNA polymerase gene, which is under the
control of an early vaccinia promoter. The
foreign gene to be expressed is cloned into a
separate expression vector under the control
of the T7 promoter. After the host cells are
infected with the vaccinia/T7 virus, the cells
are transfected with the expression plasmid.
Problems with vaccinia systems include their
cytopathic nature, and dependence on efficient
transfection rates. Mammalian cell lines can
be engineered so that the genes to be trans-
fected are stably integrated into the cell´s ge-
nome, but then a tightly controlled-inducible
promoter must be used. This method is espe-
cially advantageous when foreign protein pro-
duction must be scaled-up. Furthermore, ho-
mologous vaccinia promoter systems can be
more effective in producing secreted foreign
proteins as compared to the heterologous T7
promoter system (Pfleiderer et al., 1995).
Another vaccinia virus based expression sys-
tem utilizes defective vaccinia virus lacking
the D4R open reading frame, and a comple-
mentary cell line providing the D4R gene prod-
uct (Himly et al., 1998). Experiments done
with human secreted proteins (i.e., factors VII
and XI) showed that the defective system
produces more secreted proteins than the wild
type vaccinia. Surprisingly, recombinant
human factor VII was more efficiently
produced using the defective vaccinia recom-
binant under non-complementing conditions
(Himly et al., 1998). This suggests that the
persistence of early phase vaccinia replication,
combined with a delay in the shutoff of host
protein synthesis, can be advantageous for
foreign protein production.
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1.4.2. Alphavirus vectors
Semliki Forest (SFV) and Sindbis (SIN)
viruses together with Venezuelan equine
encephalitis virus are used as vectors for the
expression of heterologous proteins in many
diverse cells types (Makrides, 1999; Garoff
and Li, 1998; Agapov et al., 1998). Alphavirus
replicon vectors are self-replicating RNA
molecules which include the genes for non-
structural proteins (Nsps), while lacking the
genes of the viral structural proteins. Instead
of the structural genes, cloning sites have been
engineered to accept foreign genes for expres-
sion. The replicons are introduced into host
cells by transfection either as RNA, synthe-
sized in vitro, or as DNA under the control of
an eukaryotic promoter. Alternatively, the re-
combinant alphavirus RNA can be packaged
into viral particles in cells that have been
cotransfected with replication competent, but
packaging incompetent helper RNA coding for
the alphavirus structural proteins (Bredenbeek
et al., 1993). Although, recombination
between vector and helper genomes can gen-
erate a fully infectious virus, this usually
happens at very low frequencies (Berglund et
al., 1993). One way to prevent this recombi-
nation is to use conditional mutations to limit
the infectivity of any such recombinants
(Smerdou and Liljeström, 1999). In an im-
proved packaging system, the helper virus has
been modified so that the structural proteins
are expressed in two separate plasmids.
As in vaccinia systems, alphavirus infections
shuts off the host’s own protein synthesis,
which makes protein purification easier.
Compared to vaccinia, SFV is less cytopathic
to the host, and thereby potentially more effi-
cient in foreign protein production (Liljeström
and Garoff, 1991). Furthermore, non-patho-
genic alphavirus vectors have been developed.
For example, a Sindbis virus derivative, which
has low host cell pathogenicity due to a single
point mutation in Nsp2, demonstrates a
persistent infection, while its replication rate
is as high as the one of the wild type SIN
(Dryga et al., 1997). Although expression of
foreign proteins using alphaviruses derived
vectors can generate very high yields (up to
25% of total cellular proteins), cloning of large
foreign genes into replicons can be problem-
atic (Liljeström and Garoff, 1991). Foreign
sequences of about 2 kb are usually stable in
SIN vectors, whereas various inserts over 3
kb were rapidly deleted suggesting that the
packaging capacity of the virion had been
exceeded (Pugachev et al., 1995). Besides
tissue and suspension culture applications of
alphavirus replicons, in situ infections and
foreign protein expression have been accom-
plished in the neurons of rat hippocampal
slices (Schlesinger and Dubensky, 1999). This
system has been used to produce ß-galactosi-
dase, tissue plasminogen, chloramphenicol
acetyl transferase, hemagglutinin and
Hepadnavirus proteins. Furthermore, deriva-
tives of alphavirus vectors have been used to
direct foreign protein expression in specific
cell types in a tissue (Huang, 1996; Ohno et
al., 1997).
1.4.2.1. Semliki Forest virus
Semliki forest virus (SFV) is an enveloped
RNA virus with a single strand genome of
positive polarity. SFV belongs to the Alpha-
virus genus which in turn is a member of the
family Togaviridae. The prototype virus of
SFV, used in laboratories, is considered to be
nonpathogenic to humans and has been long
studied as a model virus for the Alphavirus
genus. SFV enters the cell via receptor medi-
ated endocytosis, resulting in nucleocapsid
liberation of its RNA genome into the cyto-
plasm (Helenius et al., 1980). Two-thirds of
the genomic 42S RNA (total length ca. 11.5
kb) is translated into a polyprotein, which is
then autoproteolytically cleaved into four non-
structural proteins: Nsp1 - Nsp4 (Fig. 5) (re-
viewed in Kääriäinen et al., 1987; Strauss and
Strauss, 1994). In the initial stages of SFV
infection, a RNA replication complex, is
formed from the intermediate translation prod-
ucts Nsp123 and Nsp4 and is needed to
recognize the 42S RNA plus strand for tran-
Introduction
15
scription of the negative strand 42S RNA
(Lemm and Rice, 1993a, 1993b). Later in
infection the intermediate Nsp123 is pro-
teolytically processed into the final products,
Nsp1, Nsp2 and Nsp3, after which the tran-
scription of the minus strand 42S RNA will
be terminated. According to the genetic
criteria, all nonstructural proteins are needed
to form the replication complex. Replication
occurs in association with modified endo-
somes and lysosomes called cytopathic vacu-
oles type I (CPVI) (Froshauer et al., 1998;
Peränen and Kääriäinen, 1991). The structural
proteins: capsid protein and envelope glyco-
proteins E1, E2 and E3 are transcribed from a
subgenomic 26S RNA (reviewed in Strauss
and Strauss, 1994). The functions of individual
Nsps are briefly reviewed below.
1.4.2.1.1. Nsp1
Nsp1 (537 aa) is multifunctional enzyme
catalyzing the capping of viral mRNA. Firstly,
it is a methyltransferase (MT) (Mi et al., 1989,
Mi and Stollar, 1991; Laakkonen et al., 1994).
Nsp1, like the methyltransferase purified from
the vaccinia virion can methylate GTP in the
presence of S-adenosyl-L-methionine
(AdoMet) (Laakkonen et al., 1994, Martin and
Moss, 1976). Secondly, Nsp1 has been shown
to form a covalent complex with 7-methyl-
GMP thus providing at least the first reaction
catalyzed by guanylyltransferases (GT) (Ahola
and Kääriäinen, 1995). The capping reaction
of viral mRNA catalyzed by Nsp1 differs from
the capping of eukaryotic mRNA and many
other viral mRNA by requiring methylation
of guanine before covalent complex formation
between the guanylyltransferase and 7-methyl-
guanylate (Fig. 6) (Ahola and Kääriäinen,
1995). The 7-methyl-guanylate is probably
bound to Nsp1 through a phosphoamino bond
either on a lysine or on a histidine. Further-
more, Nsp1 also assists in the initiation of mi-
nus strand synthesis (Hahn et al, 1989b).
When Nsp1 is expressed alone in HeLa cells
by transfection, it associates with the plasma
membrane as well as with endosomes and ly-
sosomes (Peränen et al., 1995). The tight mem-
brane association of Nsp1 is partly due to
palmitoylation on amino acids Cys418-Cys420
(Peränen et al., 1995; Laakkonen et al., 1996).
When the palmitoylation sites are mutated, the
protein remains enzymatically active and
bound to membranes (Laakkonen et al., 1996),
though less tightly as compared to the wild
type (i.e., the nonpalmitoylated mutant form
could be released from the membranes with 1
M NaCl, whereas wt Nsp1 could be released
only with 50 mM sodium carbonate, pH 12).
Figure 5. Proteolytic processing of the nonstructural and structural proteins of Semliki Forest virus.
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In addition, the morphology of cells infected
or transfected with nonpalmitoylated Nsp1
differs from wt by showing fewer filopodia
like structures than the wt Nsp1.
1.4.2.1.2. Nsp2
According to what is presently known, Nsp2
(799 aa) is responsible for three different
enzymatic activities in SFV replication. Firstly,
it is an autoproteinase containing a papin-like
thiol proteinase at its C-terminal region (Hardy
and Strauss, 1989). Secondly, it is an RNA
helicase (Gomez de Cedron et al., 1999),
which has single stranded RNA-stimulated
ATPase and GTPase activities (Rikkonen et
al., 1994). Thirdly, Nsp2 is a triphosphatase,
which catalyzes the first reaction in mRNA
capping (Vasiljeva et al., 2000). Moreover,
Nsp2 has been reported to act on the regula-
tion of negative strand synthesis, and is
required for the synthesis of the subgenomic
26S RNA (Hahn et al., 1989b). About half of
the Nsp2 is transported into the nucleus during
infection, and this transport is mediated by
nuclear signal sequences (Peränen et al., 1990;
Rikkonen et al., 1992). SFV in which the
nuclear targeting signal of Nsp2 is removed,
has been reported to be apathogenic in mice
(Rikkonen et al., 1996).
1.4.2.1.3. Nsp3
Nsp3 (482 aa) is an essential subunit for the
replication complex although its specific func-
tions are still not known. Studies of SIN Nsp3
have suggested that the polyprotein interme-
diates have distinct essential functions in the
synthesis of negative strands during the early
phases of RNA replication (Lemm et al., 1994;
Shirako and Strauss 1994). SIN Nsp3 has been
reported to affect negative-strand RNA syn-
thesis, and possibly also the synthesis of
subgenomic mRNA (Wang et al., 1994;
LaStarza et al., 1994b). When the localization
of SFV Nsp3 was studied by indirect immun-
ofluorescence it was found to be mainly in
vacuole like structures both in infected as well
as transfected cells (Peränen and Kääriäinen,
1991).
The N-terminal region of different Nsp3s are
very conserved among the alphaviruses, and
part of that sequence has homology to rubella
virus, hepatitis E virus, and coronaviruses
sequences (X-motif, Koonin and Dolja, 1993).
Recently, through genome sequencing, it had
become apparent that this domain can be found
in bacteria, animals and plants and it shows
homology to the nonhistone region of macro
histone 2 (Pehrson and Fuji, 1998). The
National Center for Biotechnology Informa-
tion (NCBI) has assigned this domain as
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Figure 6. Reactions involved in capping of alphavirus mRNA (A) and eukaryotic mRNA (B).
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DUF27 with an unknown function. Moreover,
this domain has significant homologue to one
yeast ORF which has been associated with
adenosine-diphosphate-ribose-1-phosphate
(Appr-1"-p) processing activity (Martzen et
al., 1999). Conservation of this region during
evolution suggests an important function(s) for
this domain.
The C-terminal part of alphavirus Nsp3 is
not conserved among alphaviruses, and var-
ies both in sequence and in length from 134
aa (Middel-burg virus) to 246 aa (O’nyong-
nyong virus) (Strauss and Strauss, 1994). This
domain is rich in acidic residues, as well as in
serine and threonine and appears to be devoid
of any predicted secondary structures. The
region also contains duplicate amino acid (aa)
sequences i.e., ADVPEPA, PAPR and
TFGDFD, suggesting that this region has
evolved through duplication events. Nsp3 is
the only alphavirus nonstructural protein modi-
fied by phosphorylation (Peränen et al., 1988;
Li et al., 1990).
1.4.2.1.4. Nsp4
Even though direct evidence is still lacking,
Nsp4 (614 aa) most probably is the catalytic
subunit of the alphavirus RNA-replication
complex (Barton et al., 1988). Nsp4 has
conserved a GDD motif found in other viral
RNA polymerases (Argos, 1988), and a SIN
temperature sensitive mutant, ts6, has been
reported to fail in the synthesis of RNA due to
a mutation in Nsp4 (Sawicki et al., 1981a
1981b, Hahn et al., 1989). Nsp4 has also been
reported to be an autoproteinase (Takkinen et
al., 1990).
2. PURIFICATION STRATEGIES FOR
RECOMBINANT PROTEINS
Purification is an important step in the pro-
duction of recombinant proteins. The char-
acteristics of industrial-scale purification
schemes, such as conventional chromatogra-
phy, have a significant impact on the final
cost of production. It is often more efficient
to use one of the available tags to ‘fish out’
the target protein. The purpose for which the
protein will be used determines required
degree for its purity and authenticity. To
purify intracellularly produced proteins the
cells are harvested and lysed, which naturally
contributes to the complexity of the protein
mixture. The advantage of intracellular ver-
sus secreted protein is the volume to be
handled, i.e., the secreted proteins usually
exist diluted in the culture medium. Isolation
of a desired protein from the medium follows
the general scheme: (1) concentration by pre-
cipitation, ultrafiltration, batch adsorption or
partition in an aqueous phase system (2)
enrichment by chromatography or partition
(3) high resolution purification: by chroma-
tography and/or immuno adsorption (4) final
concentration (Menge et al., 1987). If fetal
calf serum (FCS) is used in cultivation,
bovine serum albumin and globulins will be
the most abundant proteins in the superna-
tant. The interaction of albumin especially
with hydrophobic proteins represents a
significant problem for the effective purifi-
cation of minor constituents.
Even though there are many existing
examples as well as heuristics and complex
algorithms for suggesting the potential of
purification processes, no universal scheme
has been developed which could be applied
to all proteins. There are a variety of differ-
ent methods which can be used to purify pro-
teins, but only chromatographic purification
methods such as affinity, ion exchange,
reversed phase and gel filtration chromatog-
raphy will be briefly reviewed here.
2.1. CONVENTIONAL CHROMATOGRAPHY
Chromatographic methods (size exclusion,
ion exchange, reversed phase, hydrophobic
interaction and affinity based) can be utilized
either in traditional, low pressure or high-
performance liquid chromatography instru-
mentation. In addition to liquid-solid chroma-
tography there is liquid-liquid chromatogra-
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phy which is analogous to gas-liquid chroma-
tography (Cichna et al., 1995). There are also
many other types of chromatography methods
e.g., liquid adsorption chromatography, frontal
chromatography, displacement chromatogra-
phy covalent chromatography and membrane
chromatography (Mao et al., 1993; Heeter and
Liapis, 1998; Freitag, 1999; Caldas et al.,
1998; Zeng and Ruckenstein, 1999).
2.1.1. Ion exchange chromatography
Ion exchange chromatography (IEC) has
been the most widely used technique for the
isolation and purification of biological macro-
molecules since the 1950s (Choudhary and
Horváth, 1996). IEC is able to separate almost
any type of charged molecules, from large pro-
teins to small nucleotides and amino acids. The
ion exchanger are insoluble solid matrices
containing fixed ionogenic groups which bind
reversibly to sample molecules (proteins, etc.).
Desorption is then brought about by increas-
ing the salt concentration or by altering the
pH of the mobile phase. The two major classes
of ion exhangers are cation exchangers and
anion exchangers, having negatively and posi-
tively charged functional groups, respectively.
Ion exchange containing diethyl aminoethyl
(DEAE) or carboxymethyl (CM) groups are
most frequently used.
Since the protein is covered by a hydrophilic
layer, electrostatic interactions have a major
role in the retention of proteins. In addition to
size, geometric form as well as hydrophopic
and van der Waals interactions affect the sepa-
ration (Stålberg, 1999). Nevertheless, the ma-
jor property which govern the adsorption to
an ion exchanger is the net surface charge of
the protein. Since surface charge is the result
of weak acidic and basic groups on proteins,
separation is highly pH-dependent. The opti-
mum pH range for IEC for many proteins is
within 1 pH units of the isoelectric point. Many
retention models have been examined but the
complexity of the adsorption process for a pro-
tein to solid surfaces makes it difficult to con-
struct physical models for the interactions
(Stålberg, 1999). Gradient elution with increas-
ing salt concentration is most commonly used
in the IEC. The higher the net charge of the
protein, the higher the ionic strength needed
to bring about desorption. Thus, to optimize
selectivity in ion exchange chromatography,
the pH of the running buffer is chosen so that
sufficiently large net charge differences among
the sample components are created.
2.1.2. Reversed phase chromatography
Reversed phase chromatography (RPC) can
be utilized to separate compounds according
to their hydrophobicity (Geng and Regnier,
1984). Unlike many other methods RPC is
able to separate closely related and structur-
ally disparate substances, even at picomolar
levels (Aguilar and Hearn, 1996; Pearson et
al., 1982).  In RPC, silica particles covered
with chemically-bonded hydrocarbon chains
represent the lipophilic phase (C2 to C18),
while an aqueous mixture of an organic sol-
vent surrounding the particle represents the hy-
drophilic phase (Henry, 1991; Zhou et al.,
1991). Depending on the extractive power of
the eluent, a greater or lesser part of the sample
component will be retained reversibly by the
lipid layer of the particles. The partitioning of
the sample components between the two
phases will depend on their respective solu-
bility characteristics. Less hydrophobic com-
ponents will end up primarily in the hydro-
philic phase while more hydrophobic ones will
be found in the lipophilic phase. This can be
affected by the addition of an organic solvent
which is soluble in the hydrophilic phase.
Some commonly used organic solvents, in
order of increasing hydrophobicity are metha-
nol, propanol, acetonitrile, and tetrahydrofu-
ran. Separated components can be directly
subjected to further analysis such as Edman
sequencing or electrospray mass spectrometry.
The ability of a stationary phase (lipophilic
phase) to discriminate between two compo-
nents is reflected by the volume between the
peak maxima of the corresponding zones after
passing through the column (Aguilar and
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Hearn, 1996). Along with partitioning, mecha-
nism adsorption operates at the interface
between the mobile and the stationary phases
(Melander et al., 1984). Thus, the retention of
hydrophobic components will be greatly in-
fluenced by the thickness of the lipid layer. A
C18 layer is able to accommodate more hydro-
phobic material than C8 or C2 ones. For hy-
drophilic components, changing from a C18
to a C2 layer influences the separation very
little since only the surface area of the lipid
layer is active. The mobile phase can be con-
sidered as an aqueous solution of an organic
solvent, the type and concentration of which
determines the extractive power. Moreover,
according to experimental data, components
interact with the chromatographic surface in
an orientation-specific manner (Chicz and
Regnier, 1990; Regnier, 1987). RPC has been
utilized for purification of a variety of proteins
and peptides e.g., aprotinin, cytochrome C,
bovine serum albumin, fibrinogen, insulin and
lysosyme (Honda et al., 1992; Nimura et al.,
1992). Even though some proteins have been
reported to maintain their native structure
during RPC (e.g., insulin, thyroid-stimulating
hormone, growth hormone), in most cases
denaturing conditions are required which
might limit the use of RPC (Welinder et al.,
1986; Welinder et al., 1987; Forage, 1986;
Chlenov et al., 1993).
2.1.3. Gel permeation chromatography
The principle of gel permeation chromatog-
raphy (GPC; size exclusion or gel filtration
chromatography) is based on molecular
volumes. Large molecules are excluded from
the matrix, whereas intermediate size molecule
can partly enter and only small molecules can
freely enter the matrix. The porous three
dimensional matrix acts as a steric barrier to
solute molecules as they attempt to equilibrate
with liquid inside and outside the bead. While
purifying the protein GPC can also be used to
estimate approximate molecular weights.
Furthermore, gel filtration can be used for
desalting or buffer changing when the
fractionated size of the gel is small (e.g., Bio-
Gel 6, Sephadex G-25) allowing the protein
to elute in the void volume.
The choice of the appropriate column type
depends on the molecular size and physical
properties of the proteins to be separated. A
fraction of the internal volume which is ac-
cessible to a solute molecule can be described
by a constant Kd, which can be calculated with
experimentally determined elution volumes.
A column should be chosen so that separa-
tions occur in the linear part of the Kd vs. the
molecular weight plot (van Dijk and Smit,
2000). However, it is practically impossible
to adjust the pH and ionic strength so that the
proteins are in an equal state, since at the iso-
electric point the shape of globular and poly-
mer coil proteins relieve compact and soft
sphere, respectively. Furthermore, the ionic
strength of the buffer used may affect the size
of the proteins. Experiments with neutral dex-
trans and charged proteins showed that the
effective protein size increases with decreas-
ing ionic strength due to the reduction in elec-
trostatic shielding (Pujar and Zydney, 1998).
Thus, although GPC is viewed as size-based
separation process, there is considerable evi-
dence for the importance of electrostatic in-
teractions as well. GPC has been used in the
renaturation procedure (Müller and Rinas,
1999; Batas and Chaudhuri, 1999). For ex-
ample heterodimeric platelet-derived growth
factor was purified from inclusion bodies af-
ter denaturation with Gdn-HCl (Müller and
Rinas, 1999). Renaturation of this growth fac-
tor involved folding into an active hetero-
dimeric form during GPC while circumvent-
ing aggregation observed when refolding was
carried out by dilution.
2.2. AFFINITY CHROMATOGRAPHY
Affinity chromatography together with re-
combinant DNA-technology offers a simple
and fast technique to purify proteins to high
purity with a single purification step (Scouten,
1991). Fusion can be made on either side or
Introduction
20
both sides of the target gene depending on spe-
cific application, but the majority of fusion
proteins place the tag at the N-terminus of the
protein (Nilsson et al., 1997). Genetic manipu-
lation of the protein can be used to form a
cleavage site, which helps to remove the
affinity tag after purification thereby resulting
in an intact protein. Although affinity chro-
matography can be used for laboratory-scale
purification, its utilization on a preparative
scale can represent a major cost for the final
protein product.
Successful separation by affinity chromatog-
raphy requires that a biospecific ligand is avail-
able, and that it is covalently attached to a chro-
matographic bed material. It is important that
the biospecific ligand (antibody, enzyme, or
receptor protein) retains its specific binding
affinity for the substance of interest (antigen,
substrate, or hormone). These interactions
typically have high affinities (Kd < 10-6 M),
yet are reversible when conditions are changed
(Wilchek et al., 1984). Due to the specificity
of this recognition, it is often possible to ob-
tain 100-, 1.000- or even 100.000-fold in-
creases in purity of a protein sample (Clausen
et al., 1990). The packing material used, called
the affinity matrix, must be inert and easily
modified. Agarose is the most common sub-
stance used as a matrix, in spite of its relative
high costs. The ligands, or “affinity tails”, that
are inserted into the matrix can be genetically
engineered to possess a specific affinity. In a
process similar to ion exchange chromatogra-
phy, the desired molecules adsorb to the
ligands on the matrix until desorption is car-
ried out e.g., with a high salt concentration, a
competition reaction (e.g., imidazole), strong
chelating agents and/or low pH. Fouling of the
matrix can occur when a large number of im-
purities are present, therefore, this type of chro-
matography is usually implemented late in the
process. In addition to most common affinity
chromatography utilizing HPLC, there are also
other techniques which involve affinity, such
as affinity precipitation, affinity partitioning
of proteins using aqueous two-phase system,
foam fractionation and dye ligand chromatog-
raphy (Hoshino et al.,1998; Birkenmeier et al.,
1984; Lockwood et al., 1997; Boyer and Hsu,
1993).
2.2.1. Affinity tags
To date, a large number of different fusion
partners that range in size from one amino acid
to whole proteins capable of selective interac-
tion with ligand immobilized onto a chroma-
tography matrix, have been described (Nilsson
et al., 1997). Although a multitude of systems
have been introduced, no single affinity fu-
sion partner is ideal for all expression or puri-
fication systems. Some of the most commonly
used tags are reviewed below and listed in
Table 1.
In 1975 Porath and co-workers introduced
a method based on the interaction between the
side chains of certain amino acids, especially
histidines, on a protein surface and immobi-
lized transition metal ions. Immobilized metal
affinity chromatography (IMAC) systems have
three basic components: an electron donor
group, a solid support and a metal ion. The
metal ion (usually Ni2+, Co2+, Cu2+ or Zn2+) is
restrained in a coordination complex where it
still retains significant affinity towards mac-
romolecules (Porath, 1992). The use of
polyhistidine tags has been demonstrated in
a wide range of host cells including E. coli, S.
cerevisiae, insect cells as well as in mamma-
lian cells (Table 1). IMAC is usually performed
under nondenaturing conditions, but it is also
compatible with non-ionic detergents allow-
ing highly denaturing conditions with urea and
guanidium-HCl (Smith and Roth, 1993). Also
an organic solvent (isopropanol) can be used
to increase the purification efficiency (Franken
et al., 2000). The elution is usually performed
by competition with imidazole, lowering pH,
or by adding strong chelating agents. IMAC
is particularly suitable for preparative group
fractionation of complex extracts and bio-
fluids, but can also be used in the high-perfor-
mance mode. Regardless of the relatively
small size of the his-tag, is has been reported
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to affect the activity of some finally purified
recombinant proteins (Janssen et al., 1995;
Pekrun et al., 1995; Büning et al., 1996).
Maltose binding protein (MBP) from E.
coli is frequently used as a fusion partner for
proteins. MBP (40 kDa) is a periplasmic pro-
tein and thereby can be employed to induce
the secretion into the periplasm. A mixture of
cellulose and starch can be utilized as a ligand
and elution can be achieved in the presence of
maltose (Srinivasan and Bell, 1998). MBP has
reported to increase the solubility of the fu-
sion protein (Hennig and Schäfer, 1998; Ko
and Pedersen 1995; Pérez-Martin et al., 1997)
and it has been successfully used as a C-termi-
nal fusion partner (Hennig and Schäfer, 1998).
Glutathione S-Transferase (GST) -fusion
vectors were first reported by Smith and
Jonhson (1988). GSTs are a family of enzymes
that can transfer sulfur from glutathione to sub-
stances such as nitro and halogenated com-
pounds, leading to their detoxication. GST
fusion proteins are bound to immobilized glu-
tathione followed by competitive elution with
reduced glutathione. Since GST is a relatively
large tag (26 kDa), in many cases it is prefer-
able to remove it by engineering a specific
cleavage site (see section 2.2.2.). GST can also
be utilized under denaturing conditions (Zhao
and Siu, 1995). However, a possible compli-
cation associated with this system is the use
of reduced glutathione for elution, since it can
affect target proteins containing disulfides
(Sassenfeld, 1990).
Staphylococcal protein A is a immuno-
globulin-binding receptor on the surface of the
gram-positive bacterium Staphylococcus
aureus. Protein A (30 kDa) and its derivative
Z shows a specific affinity for the Fc-region
of immunoglobulin G. Protein A consists of
five repetitive homologous domains (A-E),
and each of these domains alone is capable of
binding to IgG (Moks et al., 1986). The struc-
ture of the B domain (from which Z has been
derived) has been determined, revealing that
the N- and C-termini of the three-helix bundle
*hosts: B bacteria, Y yeast, I insect cells, M mammalian cells
$References: 1. Airenne and Kulomaa, 1995 2. Airenne et al., 1999 3. Smith et al., 1998 4. Hopp et al., 1988
5. Clarke et al., 1998 6. Airanne et al., 1997 7. Chubert and Brizzard, 1996 8. Srinivasan and Bell, 1998 9.
Henning and Schäfer, 1998 10. Zhou et al., 2000 11. Hansson et al., 1994 12. Neri et al., 1995 13. Rigaut et
al., 1999 14. Ong et al., 1989 15. Ortega et al., 1992 16. Schmidt and Skerra, 1993 17. Pérez-Martin et al.,
1997 18. Schmidt et al., 1998 19. Janknecht and Nordheim, 1992 20. Manoharan et al., 1997 21. Mitchell et
al., 1993 22. Lo et al., 1998 23. Stempfer et al., 1996 24. Kim and Raines, 1994 25. La Vallie et al., 1993.
Table 1. Examples of tags used for purification of fusion proteins
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structure are solvent exposed, which is
supposed to favor an independent folding of
the target protein (Gouda et al., 1992;
Jendeberg et al., 1996). Analysis of different
repeats of Z showed that there is no advan-
tage in using more than two domains
(Ljungquist et al., 1989). Protein A is secre-
tion competent and fusion proteins can be se-
creted to the E. coli periplasm and in some
cases also to the culture medium (Abrahmsén
et al., 1986; Hansson et al., 1994). Protein A
has been reported to be highly soluble and
capable of renaturation after being subjected
to denaturants such as urea and guanidium HCl
(Samuelsson et al., 1994). The need for low
pH for elution can be circumvented by the use
of competitive elution strategies based on en-
gineered competitor proteins (Nilsson et al.,
1997). Like protein A, Staphylococcal pro-
tein G, is a receptor present on the surface of
certain strains of Streptococci. Protein G is a
bifunctional protein having structurally sepa-
rate regions for affinity to serum albumin and
IgG. The serum albumin binding region has
three helix-bundle domains, very similar to that
of protein A (Kraulis et al., 1996). Elution from
a column is usually achieved with low pH or
by alternative methods such as high pH,
lithium diiodosalisylate and heat (Nilsson et
al., 1997). Protein G or different parts of the
albumin binding domain have been used as
affinity tags in protein expressed either intra-
cellularly or as secreted proteins (Samuelsson
et al., 1994).
Thioredoxin (Trx, 12 kD), the product of
the E. coli trxA gene, has been used to increase
solubility as well as a fusion partner in E. coli.
Proteins expressed as thioredoxin fusions are
likely to be soluble, since thioredoxin remains
soluble even at levels as high as 40% of the
total cellular protein (LaVallie et al., 1993;
Yasukawa et al., 1995). The other obvious ben-
efit associated with the use of thioredoxin is
that it provides partial purification i.e., the re-
combinant protein accumulates in adhesion
zones and it can be selectively released by
rapid osmotic shock treatment. Thioredoxin
also provides an affinity tag for rapid purifi-
cation, since it specifically bonds to
ThioBondTM-resin. The resin consists of co-
valently bound phenylarsine oxide on an aga-
rose-based support to which the thioredoxin’s
active site diothiol has a high affinity. The Trx-
system has been utilized to produce short
amino acid sequences (10-30 aa) which are
usually extensively degraded or insoluble
when expressed in E. coli (LaVallie et al.,
1993). Furthermore, a plasmid has been de-
veloped for in vivo biotinylation of Trx-fusion
proteins in E. coli (Smith et al., 1998).
FLAG peptide (about 1 kDa) is an eight
amino acid long peptide (Hopp et al., 1988).
The sequence of the peptide (Asp-Tyr-Lys-
Asp-Asp-Asp-Asp-Lys) is designed for maxi-
mum hydrophilicity and contains an entero-
kinase cleavage site. There are two common
monoclonal antibodies raised against this
peptide: M1 and M2. Antibody M1 binds to
the peptide in a calcium-dependent manner,
which allows gentle elution by the addition of
a chelating agent. For antibody recognition the
FLAG peptide must be located on the very N-
terminal end of the target protein. The M1
antibody recognizes only the four first amino
acids of the peptide (Asp-Tyr-Lys-Asp) allow-
ing a shorter tag to be utilized (Knappik and
Plückthun, 1994). Antibody M2 is capable of
recognizing the FLAG peptide also at other
locations in addition to the N-terminal site.
Fusion proteins bond by antibody M2 can not
be eluted with a chelating agent, but instead
by low pH or competition with an excess of
FLAG peptide (Brizzard et al., 1994). There
are also specific antibodies raised against the
FLAG peptide sequence including a methion-
ine at the N-terminus (Chubet and Brizzard,
1996).
The strong affinity between biotin and avi-
din or streptavidin have been used for vari-
ous detection, immobilization and purification
processes. Biotinylation of a protein can be
achieved by covalent coupling of biotin to its
lysine residues. The biotinylation method
introduced by Cronan (1990) utilize in vivo
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machinery for specific biotinylation which can
not be achieved in vitro. A 75 residue frag-
ment of transcarboxylase has been shown to
be a sufficiently large substrate for bio-
tinylation (Kohanski and Lane, 1990). Elution
can be performed under mild conditions with
excess biotin. Denaturing conditions may also
be utilized since avidin, as a ligand, is fairly
stable allowing purification in the presence of
1% SDS or 8 M urea (Cronan, 1990). The C-
terminal 101 residues of the E. coli biotin car-
boxyl carrier protein of acetyl-CoA carbo-
xylase, has been utilized as an affinity tag for
Fab antibody fragment in E. coli (Weiss et al.,
1994). A subunit form of transcaboxylase has
also been used as a biotinylated fusion partner
in recombinant Semliki Forest virus-infected
baby hamster kidney (BHK) and chinese ham-
ster ovarian cells (Lundström et al., 1995).
PinPoint (13 kDa, Promega) binds to strept-
avidin/avidin or monomeric avidin and can be
eluted with biotin. An alternative small affinity
tag that binds to streptavidin is Strep (10 aa)
which mimics biotin even though it is non-
biotinylated (Schmidt and Skerra, 1993). Strep
fusion proteins can be eluted under mild con-
ditions with a biotin analog, named imino-
biotin. An improved version of the strep tag is
strep-tag II which retains its binding activity
also when placed at positions other than the
C-terminus (Voss and Skerra, 1997; Schmidt
et al., 1996).
Sometimes it is convenient to have more
than one fusion partner (Scouten, 1991). The
Dual affinity fusion concept, which in addi-
tion to providing the possibility for two affin-
ity chromatographic purification steps, can
also stabilize the target protein more than is
possible with just one fusion partner (Nilsson
et al., 1997). Rigaut et al.(1999) successfully
purified several proteins with a tandem affin-
ity purification procedure. The tags used were
protein A and calmodulin-binding peptide in
combination with a TEV-cleavage site. The
first purification step involved protein bind-
ing to an IgG matrix, followed by TEV-pro-
tease cleavage. The released protein could be
separated from the protease by a second affin-
ity chromatography step using calmodulin-
coated beads. The His6-tag together with the
maltose-binding-protein have also been used
for double-affinity purification system for
several proteins in E. coli (Pryor and Leiting,
1997).
2.2.2. Cleavage
In many applications there is no need to
remove the tag since it does not interfere with
the activity of the protein of interest (Stempfer
et al., 1996). However, sometimes it is neces-
sary to remove the tag, since it can cause un-
wanted immuno responses, inactivate the fused
target protein or prevent structural determina-
tion. Several methods have been described for
site-specific cleavage treatment of the fusion
partner (Flaschel and Friehs, 1993). Careful
upstream design of the fusion protein construct
can facilitate the subsequent purification of the
target protein. Furthermore, it may allow for
integrated systems involving co-processing of
the protein and efficient removal of the affin-
ity fusion partner as well as the protease used
for the cleavage. Chemical cleavage methods
utilizing, for example, cyanogen bromide and
hydroxylamine are relatively inexpensive.
Nevertheless, the chemicals are relatively un-
specific and the reaction conditions used can
cause amino acid side chain modifications,
denaturation or partial degradation of the tar-
get protein. Enzymatic methods are preferred
due to their specificity and milder reaction
conditions required. However, the proteases
cleaving after a basic residue (enterokinase,
thrombin and factor Xa) sometimes display
nonspecific and unwanted cleavages (Nygren
et al., 1994). IgA-proteinase has been reported
to be more specific since it requires a proline
in the P2’ position (see Table 2). After
cleavage, the target protein can be purified
from the tag by affinity chromatography. Pro-
tease can also be designed to contain a tag by
which it can be separated from the target pro-
tein, and thus facilitate the purification
(Nilsson et al., 1997). For certain applications
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it is convenient to perform a site-specific
cleavage when the fusion protein is still bound
on the affinity column. An example of a protein
purified by this method is the DNA binding
domain of the glucocorticoid receptor fused
to protein A (Dahlman et al., 1989).
For some applications maintenance of an
authentic N-terminus of the protein is required.
For this purpose the initiation methionine can
be removed by cyanogen bromide or by in vitro
cleavage e.g., within the sites of specific
proteases such as aminopeptidase, enteroki-
nase or factor Xa. The authentic N-terminus
can also be obtained by using ubiquitin as a
fusion partner (Miller et al., 1989; Sabin et
al., 1989). The ubiquitin fused to human
gamma-interferon and 1-proteinase was
removed quantitatively in vivo by an endo-
genous ubiquitin-specific proteinase (Sabin et
al., 1989).
3. ANALYSIS OF POSTTRANSLATIONAL
MODIFICATIONS
Many proteins are subsequently modified in
various ways after or during the assembly of
the polypeptide chain (Wold, 1981). The ter-
minal methionine can be hydrolyzed, one or
more N-terminal residues may be removed
and/or polypeptides can be specifically
cleaved. Disulfide bonds may be formed by
oxidation of two cysteines and certain amino
acids chains can be modified by e.g., hydroxy-
lation, sulfation, acylation, glycosylation and
phosphorylation. Also prosthetic groups, such
as lipoate, are covalently attached to some pro-
teins. However, only the analysis techniques
concerning three common posttranslational
modification i.e., glycosylation, acylation and
phosphorylation are reviewed here.
3.1. GLYCOSYLATION
Many luminal, secreted and membrane pro-
teins, as well as some cytoplasmic proteins,
are modified by glycosylation. Together with
glycolipids, membrane glycoproteins are
responsible for many important functional
properties of the eukaryotic cell surface, e.g.,
cell-cell recognition and adhesion, blood group
specific antigens, virus, bacteria and protozoan
receptors, transplantation (histo-compatibility)
antigens, ion channels and many others
(Parekh, 1991). In general glycosylation is a
complex process and varies in different cell
types, and cannot be easily predicted by simple
rules. Two types of carbohydrate-protein link-
ages are found: O-linked and N-linked. O-gly-
cosidic bonds occur between the hydroxyl
group of serine or threonine and an amino
sugar, whereas N-glycosidic bonds are
between the amide nitrogen of asparagine and
Table 2. Enzymatic cleavage sites for fusion proteins. The cleavage window for protease is defined as
P2-P1  P1’-P2’, where cleavage occurs at the bond between the P1 and P1’ residues. X represent any aa.
aFor some of the enzymes, alternative sequences are also reported to be functional.
Introduction
25
the C-1 of an amino sugar residue. N-glyco-
sidic glycosylation can occur in the sequence
motif of Asn-X-Ser, or Asn-X-Thr, where X
can be any amino-acid except proline and
asparagine. N-glycans can be subdivided into
three distinct groups called ‘high mannose
type’, ‘hybrid type’, and ‘complex type’
glucans.
The determination of oligosaccharide com-
position can be demanding since saccharides
have very complex structure having branch-
ing and anomeric configurations (alpha and
beta linkages). The complete characterization
of the glycosylation of a glycoprotein entails
the determination of three variables: Firstly,
the occupancy of potential glycosylation sites;
secondly, the type(s) of oligosaccharides
present at these sites, and thirdly, the distribu-
tion of oligosaccharides structures at each site
(Ashford, 1992). To study whether the pro-
tein is modified by glycosylation, metabolic
labeling with radioactive saccharide and/or
affinity chromatography (lectin, Con-A) can
be utilized (Table 3). A radioactive sample can
be obtained by labeling either metabolically
or chemically, or a radioactive sugar nucle-
otide can be transferred from another saccha-
ride using a glycosyltransferase. In many cases
for the analysis of the saccharide composition
and structure, it is necessary to release the sac-
charides from the glycoprotein. Methods used
to release saccharides include the enzymatic
approach (endo/exoglycosidases), chemical
methods and digestion of the protein with
proteases. Since the glycoside bond between
the hydroxyl group and amino sugar can be
disrupted by alkali treatment, O-linked saccha-
rides are released by ß-elimination. However,
this technique releases other O-linked residues
e.g., phosphate. Purified glycopeptides or
saccharide moieties can be further analyzed
by RP-HPLC, gas-liquid chromatography or
thin layer chromatography (TLC). Mono- and
disaccharides can also be determinated by
paper chromatography. In addition, many
inhibitors and comparative substrates can be
utilized to alter the glycoconjugates, for
example N-linked glycosylation can be pre-
vented by tunicamycin and the elongation of
the saccharide chain can be stopped at different
stages by other specific inhibitors. Finally,
there are many other approaches to analyze
oligosaccharides such as the glycolipide
anchor method, polysaccharide lyase, the
phenolsulfuric acid assay, and mass spectrom-
etry (MS).
3.2. ACYLATION
There are three common types of lipid modi-
fications of cytoplasmic proteins: myristate
(C14-saturated fatty acid), palmitate (C16-
saturated fatty acid) and isoprenoids (farnesyl,
geranyl) (Grand, 1989; Solski et al., 1996).
Table 3. Different techniques for glycan analysis (modified from Merry, 1999).
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Some membrane proteins can also carry a
stearate (C18-saturated fatty acid) and
glycosylphosphatidylinositol anchor (Thomas
et al., 1990). Modification of the proteins by
lipids appears often to be the first membrane
binding step (McIlhinney, 1990). Lipid modi-
fications with myristate or isoprenoids, are
attached through chemically stable amine or
thioether bonds, respectively, whereas palmi-
tate is attached through a chemically fragile
thioester linkage (Bizzozero, 1995). There is
no recognition sequence for palmityolation,
but often the palmitate is attached to cysteine
residues (Dunphy and Linder, 1998). A con-
served eight amino acid sequence is the mini-
mum number of residues that provides an ef-
fective signal for myristoylation, but a large
number of eukaryotic proteins are
myristoylated at their N-terminal glycine-resi-
due via amide linkage (Solski et al., 1996).
Prenyl groups are attached to C-terminal cys-
teine residues via a thioester linkage (Glomset
et al., 1990).
Preliminary indications that a protein is
acylated can be provided by the incorporation
of radiolabeled fatty acids or by mass spec-
trometry (MS; Neubert and Johnson, 1995).
Acylation of a protein can be indicated when
discrepancies between the observed molecu-
lar weight of a peptide and the calculated mass
of the amino acids corresponds to the mass of
an acyl sequence. The specific modified amino
acid residues can be identified by tandem mass
spectrometry (MS/MS) of proteolytic peptides
(Hunt et al., 1986). The incorporated fatty acid
can also be identified by gas chromatography
after hydrolysis and methyl esterification
(Bizzozero, 1995). A sequential hydrolysis
with acid, KOH/methanol and hydroxyamine
might give information about the nature of the
bonds between the acyl-group and the protein.
Furthermore, the released fatty acids can then
be identified by liquid chromatography or
TLC. Nuclear magnetic resonance (NMR) has
been used to study C-terminal alkylation with
isoprenoid farnesyl or geranylgeranyl groups
(Anderegg et al., 1988).
3.3. PHOSPHORYLATION
Phosphorylation is generally considered to
be the most prevalent posttranslational modi-
fication of proteins. It has been shown that
many cellular processes such as signal trans-
duction, enzymatic activities, protein transla-
tion and cell division are regulated by phos-
phorylation and dephosphorylation (Hunter,
1995). Proteins can be phosphorylated at
serine, threonine and tyrosine to form O-
phosphomonoesters. Besides the commonly
occurring phosphorylated amino acid residues
in proteins, phosphomono- and phospho-
diesters have been found to be attached to
sugar residues of some oligosaccharide side
chains (Varki, 1998). One of the best known
examples of the functional phosphate esters is
the targeting of some hydrolytic enzymes to
lysosome by mannose residues that are phos-
phorylated at the C-6 hydroxyl group, known
as the mannose 6-P recognition signal. With
radioactive labeling it is possible to determine
if the protein is modified by phosphorylation.
Other techniques to detect possible phospho-
rylation are dephosphorylation with phos-
phatases and immunodetection with anti-
phosphoserine/threonine/tyrosine antibodies.
To further study the function of phosphoryla-
tion it is necessary to identify the exact phos-
phorylation sites. This can be approached by
site-directed mutagenesis, tryptic phospho-
peptide mapping followed by Edman degra-
dation or from pure peptide samples by mass
spectrometry.
To analyze the type(s) of amino acids phos-
phorylated, the protein is subjected to acid
hydrolysis, and phosphorylated amino acids are
separated by chromatographic and/or electro-
phoretic systems. In addition to peptide bonds
phosphodiester bonds are also unstable under
the reaction conditions that lead to the release
of free [32P]phosphate. As a consequence,
hydrolysis times are critical as usually no more
than 20% of the radioactivity can be recov-
ered as free phosphoamino acids. Sometimes
one-dimensional migration is sufficient to
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separate all three phosphoamino acids (Jelinek
and Weber, 1993) but often two-dimensional
(2D) analysis is required. 2D-systems can con-
sist of two successive chromatography
(Grimm and Nordeen, 1999), two successive
electrophoresis or an electrophoresis followed
by chromatography.
Peptide mapping or peptide fingerprinting
is a powerful technique to analyze phospho-
amino acid composition as well as other post-
translational modifications (i.e., glycosylation,
fatty acid acylation, methylation and acetyla-
tion). Phosphopeptide mapping (PPM) of a
digested protein can give an overall view of
how many sites are phosphorylated or it can
be used to study the effects of different treat-
ments and the site-directed mutagenesis on the
relation of phosphorylated peptides. 2D-map-
ping is an extremely sensitive technique that
requires only minor amounts of metabolically
labeled product. Resolving the peptide mix-
ture in two dimensions often yields subtle but
important clues about peptide composition.
Because cellulose is an inert material, the
peptides can be recovered from the plate for
further analysis, such as amino acid analysis
or Edman degradation.
Two-dimensional electrophoresis is an
effective method for the analysis of a broad
range of complex protein samples, and post-
translational modifications like phosphoryla-
tion. The technique sorts proteins into two
dimensions according to their isoelectric points
(IEF) and sizes (SDS-PAGE). Drawbacks of
this method are its extreme sensitivity to salts
and other impurities as well as its unsuitabil-
ity for membrane proteins. An improved varia-
tion of 2D electrophoresis utilizes immobilized
pH gradients by which the inconsistencies
among carrier ampholytes are circumvented
(Görg et al., 1988).
Mass Spectrometry (MS) is a rapid and
extremely sensitive tool for the determination
of posttranslational modifications, including
phosphorylation (Costello, 1999). By utiliz-
ing techniques such as matrix-assisted laser
desorption/ionization (MALDI) and electro-
spray ionization (ESI) MS is able to analyze a
sample below the picomolar level (Beavis and
Chait, 1996; Banks and Whitehouse, 1996).
MS with collision-induced dissociation (CID)
after  phosphopeptide  precursor-ion scan of 
m/z of 79 can be utilized to sequence phospho-
peptides (Carr et al., 1996). However, identi-
fication can sometimes be ambiguous, espe-
cially when a protein/peptide exists in com-
plex mixtures. Peptide characteristics can
make the identification process difficult or oc-
casionally impossible, i.e., negatively charged
peptides may be poorly ionized in the positive
mode thus preventing sequence analysis by
CID MS. Moreover, large peptides will not
release an informative fragmentation pattern
and small peptides (under 600 kDa) are more
likely to be lost within the region of matrix
signals. To avoid adventitious formation of
acrylamide adducts during electrophoresis,
alkylation with iodo-acetamide, 4-vinyl-
pyridine and acrylamide can be performed
prior to SDS-PAGE (Sechi and Chait, 1998).
The peptides for MS can be purified by RP-
HPLC either off- or on-line. Phosphopeptides
can be also purified by binding them to an iron-
chelating column (IMAC). MS can be used to
identify phosphorylation sites alone or in com-
bination with other methods such as phospho-
peptide mapping, 2D-electrophoresis and
Edman degradation. Phosphoprotein or
phosphopeptides prepared by enzymatic
(phosphatase treatment) or chemical degrada-
tion (ß-elimination) can be identified by their
m/z of 79 [PO3]- or 97 [H2PO4]- mass differ-
ence compared to the peptides expected from
the sequence (Neubauer and Mann, 1999). An
elegant way of determining phosphorylation
sites  utilizes on-line electrospray mass spec-
trometry, connected to an IMAC column and/
or micro liquid chromatography column.
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This study focused on the expression and
purification of truncated yeast secretory pro-
tein Hsp150, Hsp150-NGFRe fusion protein
and Semliki Forest virus nonstructural proteins
(Nsp1-Nsp4). The purpose was to analyze the
specific functions and structural features of
these proteins. Specifically, the aims were:
 to express and purify truncated Hsp150 for
structural studies (I)
 to evaluate the use of Hsp150 as a carrier
for the ectodomain of rat nerve growth fac-
tor receptor (NGFRe) (II)
 to characterize N- and O-glycosylation of
Hsp150-NGFRe (III)
 to express and purify SFV Nsp1-4 for en-
zymatic and structural studies (unpub-
lished)
 to map the amino acids in SFV Nsp1 in-
volved in methyltransferase and guanylyl-
transferease activities (IV)
 to identify and eliminate the phosphoryla-
tion sites in SFV Nsp3 (V)
 to study the effect of Nsp3 phosphorylation
on membrane association, virus life cycle
and neuropathogenicity (VI)
AIMS OF THE STUDY
Aims of the study
Materials and Methods
29
1. MATERIALS
1.1. STRAINS, CELLS AND MEDIA
Plasmid construction was performed
using the E. coli strain DH5 (Bethesda Re-
search Laboratories or Life Technologies
Inc.). E. coli strains BL21 (DE3, Novagen
Promega Corp.) and JM109 (DE3, Novagen
Promega Corp.) were used for protein
expression of SFV Nsp1-3 and their muta-
tions. The strains were grown at 37°C in L-
broth medium supplemented with ampicil-
lin (100 µg/ml).
The S. cerevisiae strains used are listed
in Table 4 and described in detail in I-III.
The yeast cells were grown at 24°C in YPD-
medium or in synthetic complete (SC)
medium (Sherman, 1991). Strains H487 and
H640 were grown in SC medium lacking
tryptophan.
Spodoptera frugiperda (Sf9) insect cells
and Autographa californica multiple nuclear
polyhedrosis virus (AcMNPV) were kindly
provided by Dr. Christian Oker-Blom (Uni-
versity of Jyväskylä, Finland). The Sf9-cells
were grown at 28°C as monolayer cultures
in TNM-FH medium (Norvacc Media) con-
taining 10% fetal calf serum (PAA Labor-
und Forschungsges M.B.H.), 100 U/ml of
penicillin, 100 µg/ml of streptomycin and
300 µg/ml of glutamine. The propagation of
AcMNPV has been previously described
(Summers and Smith, 1988).
HeLa cells were grown in Dulbecco’s
modified minimal essential medium, supple-
mented with 10% inactivated fetal calf serum
(PAA Laboratories GmbH) and 100 U/ml of
penicillin and streptomycin (Gibco BRL).
The origin and culturing of baby hamster
kidney cells (BHK21) has been previously
described (Keränen and Kääriäinen, 1974).
The Semliki Forest virus (SFV) prototype
strain was propagated in BHK cells as
previously described (Keränen and Kääri-
äinen, 1974). Vaccinia virus vTF-3 and modi-
fied vaccinia Ankara virus MVA/T7 were
kindly provided by Dr. B. Moss (National
Institutes of Health, Bethesda, MD, USA)
and propagated in HeLa and BHK cells,
respectively, as described by Fuerst et al.
(1986) and Wyatt et al. (1995).
MATERIALS AND METHODS
Table 4. S. cerevisiae strains.
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1.2. PLASMID CONSTRUCTIONS
All DNA manipulations were done ac-
cording to standard methods (Sambrook et
al., 1989). DNA fragments from the agarose
gel were isolated using a commercial kit
(Qiagen) and nucleotide sequences were
determinated by an automated ALF DNA
sequencer (Pharmacia LKB).
1.2.1. Yeast (I-III)
S. cerevisiae strains H431, H433 and
H426 were constructed with a shuttle vector
derived from YEp24 (Botstein et al., 1979)
by removing the bla gene and the 2µ repli-
cation origin (Simonen et al., 1994). A de-
tailed description of plasmid constructions
is given in I-III.
1.2.2. E. coli (IV, unpublished)
Nsp1-Nsp3 were expressed using vector
pHAT coding for six histidines in a row at
the 5’ end (Peränen et al., 1996, Hyvönen,
unpublished). The sequences encoding
Nsp1, Nsp3 (NcoI-HindIII fragment) and
Nsp2 (NcoI-BglII fragment) were cloned
under the control of a T7 promoter, which
could be induced by IPTG. Nsp1 and its
mutants were expressed using the expression
vector pBAT4 (Peränen et al., 1996).
1.2.3. Baculovirus system (unpublished)
The gene fragment encoding for Nsp4
was amplified by PCR using linearized
pPLH214 as a template (Peränen et al.,
1990). The PCR-fragment was cloned into a
pVL1392 transfer plasmid (kindly provided
by Dr. M. Summers, Texas A&M Univer-
sity, USA) to generate recombinant the plas-
mid pBNS4 (Laakkonen, unpublished). Sf9
cells were co-transfected with AcMNPV and
pBNS4 by lipofectin according to the
manufacturer’s instructions. The recombi-
nant virus AcMNPV-Nsp4 was isolated and
subcloned as described by Summers and
Smith (1988).
1.2.4. Vaccinia infection/DNA-transfec-
tion (IV- IV)
The vector used for DNA transfection
(pTSF) was a derivative of pGEM3
(Promega), where the multiple cloning site
has been changed into a site encoding the
following restriction sites: NcoI-BamHI-
BglII-HindIII (Takkinen et al., 1990). The
gene encoding Nsp3 (NcoI-HindIII) was
cloned into pTSF under the control of T7
promoter (Peränen, 1991).
2. METHODS
2.1. DELETION CONSTRUCTS AND POINT
MUTATIONS (IV-VI)
Deletion and point mutations of Nsp3
were made using pTSF3. Briefly, a linear-
ized plasmid was used to amplify fragments
of Nsp3 by the polymerase chain reaction,
and primers which generated the mutations
used are listed in V and VI. Point mutations
made in Nsp3 and Nsp1 were made using
the unique site elimination method accord-
ing to the manufacturer’s instructions (U.S.E.
mutageneis kit, Pharmacia Biotech). All the
mutations were verified by sequencing.
2.2. IMMUNOPRECIPITATION, IMMUNO-
BLOTTING AND SDS-PAGE
The immunoprecipitation methods have
been previously described (Peränen et al.,
1988). Proteins were analyzed by SDS-
PAGE in 8% or 10% gels according to
Laemmli (1970). Western analysis of pro-
teins were done on gels blotted onto nitro-
cellulose membranes (Hybond ECL,
Amersham) and visualized by using the ECL-
kit (Amersham). Anti-Nsp3 antibody was
used in a 1 to 10,000 dilution. Horse radish
peroxide-conjugated anti-rabbit antibody
was used as a second antibody in a 1 to 3,000
dilution.
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2.3. PROTEIN EXPRESSION AND PURIFICATION
2.3.1. Yeast (I-III)
Yeast cells were grown overnight and the
supernatant was subjected to further purifi-
cation as illustrated in Fig. 7. Briefly, the
proteins were concentrated by filtration or
ion exchange chromatography (IEC) and fur-
ther purified by gel filtration and IEC. Be-
tween different purification steps the sample
was concentrated with membrane filtration
(PM10, Centricon, Amicon). In IEC and gel
filtration, detection was at 280 nm, in RP-
HPLC detection was at 216 nm.
Authentic Hsp150 was initially purified
using IEC (DEAE cellulose). Hsp150 was
collected from the flow-through, and sub-
jected to dialysis against 10 mM Tris-HCl
pH 8.0. After concentration, Hsp150 was
purified by IEC (Q-Sepharose) equilibrated
with 10 mM Tris-HCl pH 8.0. Elution was
performed using an increasing gradient of
NaCl, and fractions containing Hsp150 were
pooled and desalted by gel filtration (Bio-
Gel P100). The preparation was again sub-
jected to IEC (Mono Q), and eluted under
the same conditions as truncated Hsp150 and
Hsp150-NGFRe (Fig. 7).
2.3.2. E.coli (IV, unpublished)
BL21 (DE3) or JM109 (DE3) cells car-
rying the plasmid encoding target gene un-
der T7 promoter, were grown at 37°C to an
optical density of 0.7-1.0 (measured at 600
nm). The culture was transferred to 15°C or
Figure 7. The purification schemes of truncated Hsp150 (A) and Hsp150-NGFRe (B).
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to 24°C, in the case of N-Nsp2, and produc-
tion was induced by IPTG (see the results
section for the concentrations used in dif-
ferent cases). After an 18 h incubation, 6 h
in the case of N-Nsp2, the cells were har-
vested by centrifugation at 5000 rpm for 5
min (JA-14 rotor, Beckman) and lysed by
French Press (550 Psi, three times; French
Pressure Cell Press, SLM Instruments Inc.).
The lysis buffer used contained: 50 mM Tris-
HCl, pH 8.0, 50 mM NaCl, 20% glycerol,
0.1% tween 20, 1 mM phenylmethylsulfonyl
fluoride (PMSF) and 1 mM dithiothreitol
(DTT). The lysate was then centrifuged for
20 min at 15 000 x g at 4°C and the superna-
tant, designated as S15, was used for further
studies or purification steps.
N-Nsp2 and Nsp3 were purified under
nondenaturing conditions with immobilized
metal affinity chromatography (IMAC) at
10°C followed by gel filtration. Generally,
0.5 M NaCl was added to the S15 fraction
and after 30 min incubation on ice the sample
was applied to a Ni2+-NTA-column (Qiagen)
equilibrated with buffer A (50 mM Tris-HCl,
pH 8.0, 0.5 M NaCl, 0.1% tween, 20% glyc-
erol). The column was washed with 10 vol.
of buffer A and stepwise eluted with 20-250
mM imidazole in buffer A. In the case of N-
Nsp2, before elution the column was washed
with 5 vol. of buffer A containing 5 mM ATP
and 5 mM MgCl2 followed by washing with
10 vol. of buffer A. Nsp1 was purified un-
der denaturing conditions in 6 M
guanidinium hydrochloride (Gnd-HCl), 10
mM Tris, 100 mM Na-phosphate, pH 8.0 or
7.5. The solubilized protein was applied to a
Ni2+-NTA column, and the buffer was
changed to buffer B (8 M urea, 10 mM Tris,
20% glycerol, 100 mM Na-phosphate, pH
8.0 or 7.5 ). The amount of urea was reduced
by a linear gradient (0-100%) of buffer C
(20% glycerol, 50 mM Tris pH 8.0 or 7.5,
0.5 M NaCl, 0.4 M urea or no urea) in buffer
A. Nsp1 was eluted by 167 mM or 250 mM
imidazole in buffer C.
Gel filtration was performed in buffer
containing 50 mM Tris-HCl, pH 7.5 or 8.0,
20% glycerol at a flow rate of 0.5 ml/min
and detection was at 280 nm. The molecular
weight of the purified proteins were esti-
mated according to a molecular weight stan-
dard consisting of thyroglobulin, 670 kDa,
gammaglobulin, 158 kDa, ovalalbumin, 44
kDa, myoglobin, 17 kDa and vitamin B-12,
13.5 kDa (Bio-Rad).
2.3.3. Sf9 cells (unpublished)
Sf9 cells grown in plastic bottles were
infected with AcMNPV-Nsp4 at 50 PFU/cell
with occasional shaking. After 2 hours p.i. 8
ml of medium was added and the cells were
collected at 36-48 h p.i. in cold PBS and
washed twice with RS-buffer (10 mM Tris-
HCl, pH 8.0, 10 mM NaCl, 1 mM PMSF).
The cells were harvested by centrifugation
at 5000 rpm for 5 min (Sorvall) at 4°C and
resuspended in RS-buffer. After incubation
on ice for 15 min, the cell were lysed using a
Dounce homogenizator. The cell lysate was
fractionated by centrifugation and Nsp4 was
concentrated by flotation on a sucrose gra-
dient, i.e., the sample was suspended in 67%
sucrose to a final sucrose concentration of
55% and layered on top of 60% sucrose and
overlayered by 10% sucrose in 50 mM Tris-
HCl pH 7.5, 25 mM KCl, 5 mM MgCl2. Nsp4
was also subjected to solubilization by add-
ing Triton X-100 to 0.5% prior to flotation.
The discontinuous gradient was centrifuged
at 35,000 rpm (rotor SW50.1, Beckman) for
half of hour at 4°C. Several detergents e.g.
Triton X-100, octylglycoside (17.1 mM),
Thesit (8.6 mM), Chaps (8.1 mM) in the pres-
ence (1 M or 0.5 M) or absence of NaCl as
well as sonication were used in order to solu-
bilize the protein.
2.3.4. HeLa cells (IV-VI)
The cells were grown on plastic dishes
until approximately 90% confluent. The cells
were then infected with MVA or vTF7-3, 30-
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50 PFU/cell at 37°C for 45 min with shak-
ing. The cells were washed twice with
Dulbecco-BSA and transfection with plas-
mid containing the desired gene under the
T7 promoter was carried out in OPTIMEM1
using lipofectin (Gibco BRL). The DNA and
lipofectin amounts used for 3 cm, 6 cm and
10 cm plastic plates were 1-2 µg and 5 µl, 7
µg and 12 µl, 10 µg and 50 µl, respectively.
After 3 hours post transfection the transfec-
tion mixture was replaced with MEM
medium and protein production continued
for another 2-4 hours. Unless otherwise
stated the cells were harvested in PBS
(65°C), containing 1% SDS and 10 mM NaF
(Merck).
For mass spectrometric analysis Nsp3
was immunoprecipitated and subjected to
10% SDS-PAGE. To obtain peptides suitable
for MS, Nsp3 was subjected to CNBr degra-
dation followed by trypsin digestion. The
purification scheme is described in Fig 8.
Figure 8. The purification scheme of Semliki Forest virus Nsp3 for mass spectrometric analysis.
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2.4. METABOLIC LABELING (I-III,V,VI)
Yeast cells (108/200 µl) were labeled in
synthetic medium lacking methione with 50
µCi/ml of [35S]methionine/cysteine (>1000
Ci/mmol, Amersham). For glycan analysis
the yeast cells were labeled with 300 µCi/
ml of [3H]mannose (11.5 Ci/mM, Amersham)
in medium including 0.1% glucose.
HeLa cells were labeled with
[35S]methionine/cysteine (>1,000 Ci/mmol;
Amersham) or [32P]orthophosphate (10 mCi/
ml; Amersham) as described in detail in V.
The fluorographic detection was performed
by Fuji Bas 1500 Bioimaging Analyzer in-
strument.
2.5. IMMUNOFLUORESCENCE (VI)
For immunofluorescence HeLa cells
were grown to low confluence on coverslips
and transfected with pTSF -plasmid contain-
ing Nsp3 or its mutants as described in the
section for protein expression and purifica-
tion. After 3-4 hours post transfection the
cells were fixed for 20 min with a solution
containing 4% paraformaldehyde, 11.1% (w/
v) sucrose 10 mM MES, 138 mM KCL, 3
mM MgCl2 and 2 mM EGTA. After the fixa-
tion cells were permeabilized with 0.1%
Triton X-100 for 1 min. Anti-Nsp3 antisera
were raised in a rabbit or in a guinea pig
against recombinant Nsp3. To avoid un-
specific binding both antibodies were puri-
fied by adsorption to uninfected PFA-fixed
and permeabilized HeLa cell monolayers.
The antibodies were used in a 1 to 500 dilu-
tion in Dulbecco including 0.2% BSA. The
secondary antibody was donkey rhodamine
red-X conjugated anti-rabbit IgG (Jackson
Research Laboratories Inc.) used in a 1 to
300 dilution. Microscopy was performed
using a Bio-Rad MRC1024 confocal micro-
scope (Cambridge, Mass.) connected to a
Zeiss Axiovert M135 inverted microscope
(Göttingen).
2.6. FLOTATION ANALYSIS (VI)
Flotation studies of Nsp3 and N-Nsp3,
expressed in HeLa, were performed with
protein metabolically labeled with [35S]meth-
ionine/cysteine. The cells were harvested in
RS-buffer and after a 15 min incubation on
ice the cells were lysed with a Dounce
homogenizator. A sucrose solution (67%)
was added to the post nuclear supernatant
(PNS, 10 min at 500 x g) to a final concen-
tration of 60%. The sample (0.5 ml) was lay-
ered on top of a 0.5 ml 67% (w/w) sucrose
cushion and overlaid by 3 ml of 50%, and 1
ml of 5% sucrose, modified from Caliquiri
and Tamm (1970). The sucrose solutions
were prepared in buffer containing 50 mM
Tris-HCl, pH 7.5 and 100 mM or 500 mM
NaCl. The discontinuous gradient was cen-
trifuged at 35,000 rpm for 18 hr at 4°C
(SW50.1 rotor, Beckman). Fractions of 0.5
ml were collected from the bottom of the tube
and the presence of Nsp3 or N-Nsp3 was
analyzed by immunoprecipitation followed
by SDS-PAGE. The quantitation of proteins
was performed utilizing digital imaging.
2.7. PHOSPHOAMINO ACID ANALYSIS (V)
Phosphoamino acids were analyzed by 2-
dimensional phosphoamino acid analysis.
[32P]-labeled proteins were Western blotted
onto polyvinylidene difluoride (PVDF,
Immobilon) membrane and the protein band
were excised and rehydrated with methanol
and water. Hydrolysis was carried out in 6
M HCl at 110°C for 120 min. The hydroly-
sate was lyophilized and phosphoamino acid
standards (1 µg of phosphoserine, phospho-
threonine and phosphotyrosine) were added.
The separation of amino acids was per-
formed using 2D-electrophoresis on a 20 cm
x 20 cm cellulose plate (Merck). Electro-
phoresis in the first dimension was at 1.0 kV
for 120 min in pH 1.9 buffer (88% formic
acid:acetic acid:water, 25:78:897 v/v/v) and
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in the second dimension at 1.3 kV for 45
min in pH 3.5 buffer (acetic acid:pyridine
:water, 10:1:189 v/v/v), using the HTLE-
7000 electrophoresis system (C.B.S. Scien-
tific company, Del Mar, CA). The amino acid
standards were detected by ninhydrin (0.2%
ninhydrin (w/v) in ethanol:acetic acid, 19:1
v/v) staining, and [32P]-labeled amino acid
by phosphoimager.
2.8. PHOSPHOPEPTIDE MAPPING (V)
[32P]-labeled Nsp3 or its mutants were im-
munoprecipitated with anti-Nsp3 as
described above. Cysteines were alkylated
with 20 mM iodoacetamide (10 mM DTT, 3
mM EDTA) for 15 min and resolved by 10%
SDS-PAGE. Proteins were Western blotted
onto nitrocellulose (Hybond C-extra,
Amersham) or polyvinylidene difluoride
membrane (PVDF, Immobilon). The PVDF
membrane was dried prior to detection by
phosphoimager, but the nitrocellulose mem-
brane was prevented from drying by placing
it into a plastic bag. The membrane pieces
were excised and saturated with 0.5% poly-
vinylpyrrolidone 360 at 37°C for 1 h fol-
lowed by several washes with 10% ACN.
The protein was digested with trypsin
(Promega) in 50 mM ammonium bicarbon-
ate in 10% ACN -buffer overnight at 37°C
and the bicarbonate buffer was evaporated
by several rounds of lyophilization. The tryp-
tic peptide mix was resuspended in ammo-
nium carbonate buffer pH 8.9 and spotted
onto a TLC plate (20 x 20 cm, cellulose,
Merck). Electrophoresis in the first dimen-
sion was performed at 1.0 kV for 24 min in
the same buffer, using a HTLE-7000 elec-
trophoresis system (C.B.S. Scientific Com-
pany, Del Mar, CA). The plate was air-dried
overnight before ascending chromatography
in n-butanol : pyridine : acetic acid : water
(15:10:3:12, v/v/v/v). After air-drying the
plate, the phosphopeptides were detected by
a phosphoimager.
2.9. OTHER SPECIFIC METHODS
Other methods used in this study are
listed in Table 5.
Table 5. Other methods used  in publications I-VI.
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1. HSP150 AS A CARRIER FOR
SECRETION OF RECOMBINANT PROTEINS
IN S. CEREVISIAE
To obtain proper folding and secretion of
foreign proteins in yeast, most proteins must
be fused to a carrier polypeptide. A novel
carrier polypeptide (Hsp150) was developed
by Simonen et al. (1994) from a natural yeast
secretory glycoprotein Hsp150 (Russo et al.,
1992a). The primary translation product of
the HSP150 gene consists of a signal
sequence (SS) and two subunits (I and II),
which remain noncovalently associated after
cleavage by the Kex2 protease in the Golgi
(Fig. 9) (Russo et al., 1992a, Jämsä et al.,
1994). Subunit II contains a repetitive region
consisting of a 19 amino acid peptide repeated
11 times followed by a unique C-terminal
region. Furthermore, subunit II is heavily O-
glycosylated, since its apparent molecular
weight determined by SDS-PAGE was re-
duced by hydrogen fluoride treatment from
150 kDa to 47 kDa, which corresponds to its
predicted molecular weight (Russo et al.,
1992a). Hsp150 is secreted to the culture
medium rapidly, with a half-time of 2 min
(Jämsä et al., 1994). The expression of
Hsp150 is upregulated by heat and nitrogen
starvation (Russo et al., 1992; 1993). The
Hsp150-carrier consists of 321 N-terminal
amino acids of Hsp150, which includes an
N-terminal 18 aa signal sequence (SS), sub-
unit I (54 aa), the repetitive region and 22 aa
from the non-repetitive region of subunit II
(Fig. 9).
1.1. CHARACTERIZATION OF HSP150-
CARRIER (I)
To understand better the properties of
Hsp150 as a carrier, we expressed a trun-
cated form of Hsp150 in yeast from which
the HSP150 gene was deleted. The truncated
Hsp150 consists of 315 N-terminal aa of
Hsp150 and two additional aa (Fig. 9). This
RESULTS
Figure 9. A schematic presentation of primary translation products of the coding for Hsp150 protein,
truncated Hsp150, Hsp150-NGFR
e
 and NGFR
e
. SS = signal sequence peptide (horizontal striped box),
SUB I/II = subunit I/II (diagonally striped box / gray boxes together with white box), rr = repetitive
region of subunit II (gray boxes), C = cysteine, S = serine, I = isoleusine. The potential N-glycosylation
site in NGFR
e
 (dotted box) is indicated by an N-letter. The factor X
a
 (fX
a
) cleavage site (isoleusine-
glutamate-glysine-arginine) in Hsp150-fXa-NGFRe-construct is indicated by an arrow.
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protein was purified along with the authentic
Hsp150 and subjected to circular dichroism
(CD) analysis. The ability of Hsp150 to act
as a carrier was further studied by fusing it to
the ectodomain of the rat nerve growth fac-
tor receptor NGFRe.
1.1.1. Expression of truncated Hsp150 (I)
The gene encoding truncated Hsp150 was
integrated into the leu2 locus in strain H23
lacking the chromosomal HSP150 gene
(Russo et al., 1992).  It was  placed  under
the control of the HSP150 promoter. How-
ever, according to Northern blotting analy-
sis, the truncated hsp150 was not heat-regu-
lated like the authentic gene, but was consti-
tutively expressed at 24°C, at levels higher
than authentic the HSP150. Because the trun-
cated Hsp150 lacks cysteine residues, it was
metabolically labeled with [3H]mannose in
low glucose (0.1%) medium to enhance
labeling. To study the expression and secre-
tion of truncated Hsp150, the protein was la-
beled and chased for different times with
cycloheximide (CHX) (I, Fig. 1B). Samples
from culture medium and cell lysates were
immunoprecipitated using anti-Hsp150-anti-
body, and analyzed by SDS-PAGE (I, Fig.
1C). Truncated Hsp150 migrated in gels as a
diffuse band with an apparent molecular
weight over 200 kDa. Truncated Hsp150 was
not as efficiently secreted as the wild type
Hsp150, since less than half of the truncated
Hsp150 was secreted to the medium com-
pared to the authentic Hsp150.
1.1.2. Purification of truncated and
authentic Hsp150 (I)
Strain H431, expressing truncated Hsp150
instead of Hsp150, was grown overnight in
SC medium and truncated Hsp150 was puri-
fied from the medium under non-denaturing
conditions for structural analysis (Materials
and Methods, Fig. 7A). In brief, cell culture
concentrate was then subjected to gel filtra-
tion and the fractions containing the protein
were further concentrated and subjected to
ion exchange chromatography (IEC). With
hollow fibre filtration roughly half of the
material was lost with the permeate, whereas
with the membrane filter no flow through was
detected. Elution in IEC was performed with
a linear gradient of 0-70% of 1 M NaCl.
Samples were analyzed by SDS-PAGE,
followed by detection by Western blotting.
Two layers of membranes (nitrocellulose)
were used in immunoblotting due to the facile
penetration of the protein. The majority of
truncated Hsp150 eluted in the void volume
(I, Fig. 2A, peak 2.5), whereas a small portion
eluted later (I, Fig. 2A, peaks 13.7-17.7). The
IEC fractions containing the protein were
pooled, concentrated and gel filtrated. Four
fractions were collected according to the ab-
sorbance at 280 nm. Three out of the four
fractions contained truncated Hsp150 (data
not shown), but due to the protein’s hetero-
geneous migration on gel filtration, only the
fraction eluting at 15.8-17.7 min was used
for further analysis (I, Fig. 2B). Approxi-
mately 10% of this fraction was further puri-
fied by reversed phase high performance
liquid chromatography (RP-HPLC) (I, Fig.
2C). Three main peaks (I, Fig. 2C) were col-
lected and subjected again to RP-HPLC. N-
terminal sequencing from all three peaks gave
identical results, suggesting that the differ-
ences observed during the purification steps
were due to heterogeneous glycosylation. In
authentic Hsp150, subunit I is cleaved off in
late Golgi, but remains non-covalently at-
tached to subunit II (Russo et al., 1992a).
Since subunit I was not detected in any of
the purification steps of truncated Hsp150, it
is apparently attached to the C-terminal part
of authentic Hsp150.
Authentic Hsp150 was also purified for
structural characterization. When Hsp150
was expressed in sec7 mutant cells, it was
not retained in the Golgi complex under re-
strictive conditions like other secretory pro-
teins, but was secreted into the medium
(Russo et al., 1992a). Thus, to facilitate its
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purification, Hsp150 was expressed in
SF821-8A cells (sec7) and purified from YPD
and SC medium at 37°C. Hsp150 was puri-
fied from the supernatant with three differ-
ent IECs (for details see Materials and Meth-
ods). In the last IEC (Mono Q) the proteins
eluted with an increasing gradient of NaCl.
(I, Fig. 3A). According to N-terminal se-
quence analysis, the major elution peak con-
tained both Hsp150 subunits, which could be
resolved by RP-HPLC into separate fractions
(I, Fig. 3B).
1.1.3. Structural features (I)
The circular dichroism (CD) spectrum of
purified, truncated subunit II was then deter-
mined. Half of the fraction identified in I, Fig.
2B, was analyzed by CD. The spectrum of
truncated subunit II had its minimum at 200
nm, demonstrating that it lacked any regular
secondary structure (I, Fig. 5A). When au-
thentic Hsp150, containing subunits I and II
non-covalently associated to each other, was
analyzed, both random coils and some ß-
sheets were detected (I, Fig. 5B). Thus, the
ß-sheet elements evidently were in subunit I
and/or the C-terminal region of subunit II.
To analyze the secondary structure of the
consensus peptide of the repetitive region of
Hsp150 subunit II (I, Fig. 6A and 6B), a con-
sensus 19 aa peptide was synthesized and
subjected to NMR spectroscopy. The peptide
lacked any preferred secondary structure (I,
Fig. 7A and 7B). Thus, the repetitive region
of subunit II has a random coil structure. This
is due to the amino acid sequence alone, and
not to the O-glycans.
To characterize the O-glycans of Hsp150
subunit II, authentic Hsp150 was produced
in SF821-8A cells, labeled with [3H]mannose
and subjected to SDS-PAGE. Labeled sub-
unit II was eluted from the gel, and the buffer
was changed by gel filtration (Bio-Gel P6).
The O-glycans were detached from the
polypeptide by ß-elimination and purified by
gel filtration (Bio-Gel P6 I, Fig. 4A). Accord-
ing to thin layer chromatography (TLC), the
O-glycans were di-, tri-, tetra- and penta-
mannoses presented in the ratio of 4:1:1:1,
respectively (I, Fig. 4B and 4C).
1.2. SECRETION AND AUTHENTICITY OF
HSP150-NGFRe(II)
To further study Hsp150 as a carrier, it
was fused to the N-terminus of the extracel-
lular domain of the rat nerve growth factor
receptor p75 (NGFRe). The fusion protein
was designated Hsp150-NGFRe (Fig. 9).
NGFRe is a plasma membrane protein, and
binds all known neurotrophic factors with low
affinity (Chao, 1992). NGFRe is a cysteine
rich (24 cysteines) protein, and has a high
sequence homology to the ectodomain of
tumor necrosis factor receptor (TGFRe)
(Radeke et al., 1987). Based on the crystal
structure of TGFRe and molecular modeling,
NGFRe is supposed to consists of four
domains, each having three disulfide bonds
arranged into an elongated structure (Holkeri
et al., 1998). NGFRe contains one potential
N-glycosylation site at Asn32 (Baldwin et al.,
1992).
1.2.1. Expression of Hsp150-NGFRe (II)
To study whether Hsp150 can act as a
carrier for NGFRe and lead it out from the
yeast ER to the culture medium, a DNA frag-
ment encoding NGFRe (aa 1-223) was fused
to the C-terminal end of HSP150. The chi-
meric gene was integrated into the genome
of strain H23 (Russo et al., 1992a), which
contains a disrupted copy of the HSP150
gene, to create strain H426. Strain H426 was
grown in SC medium to different cell densi-
ties, and samples from the medium were ana-
lyzed for the fusion protein by SDS-PAGE
followed by Coomassie blue staining. The
fusion protein appeared as a heavy band at
the top of the gel indicating that it was effi-
ciently expressed, stable, heterogenous and
efficiently secreted into the medium. It was
the major protein in the medium (several
Results
39
milligrams per liter). Only small portions of
the fusion protein remained cell-associated.
Anti-Hsp150 antiserum and anti-NGFRe-anti-
serum recognized two species of the fusion
protein, i.e., a band at approximately 180 kDa
and a larger protein. The larger form was N-
glycosylated, since the synthesis of this form
could be prevented by tunicamycin (TM), an
inhibitor of N-glycosylation. Inhibition of N-
glycosylation did not prevent the fusion
protein from being secreted.
To study secretion of NGFRe in the absence
of Hsp150, it was fused to the signal peptide
of yeast invertase (Fig. 9). When expressed
in S. cerevisiae, NGFRe was translocated into
the yeast ER, since it was N-glycosylated (II,
Fig. 2B). However, no NGFRe was detected
in the medium. Apparently it remained in the
ER because the N-glycan was not elongated.
Thus, NGFRe was able to acquire a secretion-
competent conformation only when fused to
the Hsp150-carrier.
1.2.2. Purification of Hsp150-NGFRe (II)
Hsp150-NGFRe was purified from the
culture medium (see Materials and Methods,
Fig. 7B) of strain H426. In brief, the protein
was purified with IEC (Q-sepharose) and gel
filtration (Superdex-75). In gel filtration the
fusion protein eluted in the void volume, in
an estimated concentration of 0.4 µg/µl. This
preparation is referred to as semipurified
Hsp150-NGFRe, and it was used for ligand-
binding assays (see below) as well as for
polyclonal antibody production.
About one fifth of the semipurified
Hsp150-NGFRe preparation was further pu-
rified by IEC and RP-HPLC (see Materials
and Methods for details). The fusion protein
was eluted in the 18.5 - 27 min fractions as
detected by immunoblotting (II, Fig. 4).
These fractions were pooled, concentrated
and further purified by RP-HPLC. The fusion
protein was eluted in the 14-20 min fractions,
which were pooled. N-terminal sequencing
revealed two signals corresponding to the N-
terminal sequences of subunit II, and subunit
II missing the three N-terminal amino acids
(II, Fig. 4B). The molar ratio between these
two species was 3:1.
Folding of the NGFRe portion was studied
by examining its ability to bind NGF. In the
competition experiments, the semipurified
fusion protein reduced the cross-linking of
NGF to authentic NGF receptors of human
A875 melanoma cells (II, Fig. 5). This indi-
cates that NGFRe fused to Hsp150 could
obtain its ligand-binding conformation in
yeast cells, and that the yeast N-glycan did
not prevent ligand-binding.
1.3. GLYCOSYLATION OF NGFRe (III)
Hsp150 is heavily O-glycosylated at most
of its potential sites, but has no N-glycans
(I). In contrast, authentic NGFRe contains 41
potential sites for O-glycosylation, none of
which are used, and one N-glycosylation site,
which is glycosylated. To determinate
whether the NGFRe portion was O-glyco-
sylated in yeast, we made a construct where
NGFRe could be detached from the carrier in
vitro. The factor Xa-cleavage (fXa) site was
cloned between Hsp150 and NGFRe, and
the chimeric gene was integrated into the
genome of strain H23 to create strain H451.
The fusion protein was labeled with [35S]
methionine/cysteine chased with CHX, and
immunoprecipitated from medium and cell
lysate samples with anti-Hsp150 and anti-
NGFRe antisera. According to these pulse-
chase experiments, the fusion protein
Hsp150-fXa-NGFRe was efficiently secreted
to the medium, and had an apparent size of
over 200 kDa (III, Fig. 2). The fusion protein
was the major protein in the medium, and
only a small percentage remained unsecreted
inside the cells (III, Fig. 2). Furthermore, pre-
vention of N-glycosylation by TM appeared
to have only a minor effect on the secretion
efficiency of the fusion protein.
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The fusion protein was labeled with
[35S]methionine/cysteine in the presence of
TM and subjected to in vitro digestion with
fXa. The digestion produced two fragments:
one cleavage product migrated in SDS-PAGE
like a 48 kDa and another like a 36 kDa pro-
tein (III, Fig. 3). Since Hsp150 has no me-
thionines and only one cysteine, and NGFRe
has 24 cysteine residues, the released
Hsp150-carrier was not visible in the
fluorograph. The 48 kDa protein was most
probably NGFRe since it was similar in size
(Welcher et al., 1991). In addition, authentic
NGFRe comigrated with the 48 kDa protein
(III, Fig. 4). Since the 36 kDa product con-
tained similar amounts of [35S]-label as
Hsp150-NGFRe, the secondary cleavage site
was apparently located at the cysteine-free
C-terminal portion of NGFRe. Cleavage at the
fXa-site probably exposed a secondary cleav-
age site for the fXa preparation, since the fu-
sion protein which lacked a fXa site was not
cleaved at all (not shown).
To analyze O-glycosylation of NGFRe the
fusion protein was labeled with [3H]mannose
in the presence of TM. Hsp150-NGFRe was
subjected to factor Xa digestion, precipitated
with trichloroacetic acid (TCA) and analyzed
by SDS-PAGE. Since no label was detected
in the 48 kDa and 36 kDa products, the
NGFRe portion was not detectably O-
glycosylated (III, Fig. 3). To study whether
the Hsp150-carrier inhibited O-glyco-
sylation of NGFRe, the gene encoding NGFRe
was cloned into strains H23 and H4 (sec18-
1) to create strains H487 and H640, respec-
tively. The protein was labeled with [35S]
methionine/cysteine, in the presence or ab-
sence of TM, immunoprecipitated using anti-
Hsp150-NGFRe-antiserum and resolved
with SDS-PAGE. In the absence of TM,
NGFRe migrated as a 48 kDa protein and
when N-glycosylation was prevented, like a
45 kDa protein in both strains (III, Fig. 4).
When the oligosaccharides of NGFRe were
labeled with [3H]mannose in strain H487, a
48 kDa protein could be seen whereas in the
presence of TM no incorporated [3H]mannose
could be seen, indicating that NGFRe is not
O-glycosylated when expressed alone. As a
control, HSP150-NGFRe was integrated into
the genome of strain H4 (sec18) to create
strain H538. When protein secretion was
blocked in the ER, the Hsp150-NGFRe fu-
sion protein migrated like a 130 kDa protein
and it could be labeled with [3H]mannose (III,
Fig. 4). Thus, the Hsp150  portion of
Hsp150-NGFRe is heavily O-glycosylated,
whereas the NGFRe portion has one N-gly-
can but no O-glycans.
Next, the effect of folding on glycosylation
was studied. The conformation of Hsp150-
NGFRe was distorted by preventing di-
sulfide bond formation between cysteines
using the reducing agent dithiothreitol (DTT).
Hsp150-NGFRe was labeled with [35S] me-
thionine/cysteine in the presence of DTT,
followed by a chase in the absence of DTT
but with CHX present. Immunoprecipitation
from the medium was performed with anti-
Hsp150-NGFRe antiserum, followed by
SDS-PAGE. The fusion protein synthesized
in the presence of DTT migrated more slowly
than authentic molecules, indicating more
extensive N-glycosylation (III, Fig. 5, lanes
7 and 5). When N-glycosylation was pre-
vented by TM, the DTT block did not affect
the size of the fusion protein (III, Fig. 5, lanes
3 and 1). We suggest that under unusual con-
ditions disulfide bond formation and folding
compete with N-glycosylation. Once Asn34
emerges in the ER lumen, it is N-glycosylated
only if folding and disulfide bond formation
in its vicinity have not occurred. This leads
to heterogenous occupation of the Asn34 site.
When disulfide bond formation is prevented,
the Asn34 of all the molecules are glyco-
sylated.
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2. EXPRESSION, PURIFICATION AND
PROPERTIES OF SFV NSPS
Even though Semliki Forest virus (SFV)
has been well studied as a model for alpha-
viruses, its viral RNA replication and host
interactions during infection are not well un-
derstood. To overcome the problems of in-
finitesimal quantities of nonstructural pro-
teins (Nsp) produced during infection and to
characterize the properties of individual Nsps,
these proteins were expressed individually in
different expression systems.
2.1. EXPRESSION AND PURIFICATION OF NSPS
(UNPUBLISHED)
The approach we took was to express the
Semliki Forest virus nonstructural proteins
(Nsp1-4) individually in E. coli and a
baculovirus expression system (BVS) to pro-
duce and purify enough of each protein for
enzymatic and structural analysis. Optimal
growth conditions (e.g., temperature, time)
and IPTG-concentration used for induction,
were determined experimentally and condi-
tions producing the highest solubility of the
protein (i.e., highest protein concentration in
S15) during expression were chosen. All the
proteins produced were resistant to pro-
teolytic degradation and relatively stable
against thermal degradation even though
some structural decomposition was observed
with Nsp3 and N-Nsp2 upon freezing and
thawing (data not shown).
2.1.1. Expression of Nsp1 in E. coli
(unpublished)
There have been several attempts to purify
Nsp1 from E. coli (Hyvönen, unpublished;
Ahola, unpublished, Vihinen, unpublished;
Karhi, unpublished). To facilitate purification
the nsp1 gene was cloned into pHAT, which
encodes a tag of six histidines that is used in
metal-chelating affinity chromatography
(Peränen et al., 1996; Hyvönen, unpub-
lished). The cells were grown to an optical
density of 0.7-1.0 at 600 nm, and expression
was induced at 15°C with 500 µM IPTG.
Initially, when Nsp1 was expressed from this
plasmid after IPTG induction, it did not bind
to an IMAC-column (Hyvönen, unpub-
lished). However, Nsp1 with its his-tag could
be purified under denaturing conditions when
the S15 fraction from the cell lysate was
treated with 6 M guanidinium-HCl (Fig. 10).
Nsp1 was eluted in 167 (Fig. 10, lane 5) or
250 mM imidazole in 0.4 M urea. Purifica-
tion was also performed in the presence of ß-
mercaptoethanol in the washing and elution
buffers, which also contained 0.1 M KCl and
2 mM MgCl2. Unfortunately, all attempts to
Figure 10. Expression of Nsp1 and its purifi-
cation utilizing denaturing conditions. His6-Nsp1
was expressed in E. coli by induction with 500
µM IPTG at 15°C. After overnight incubation the
cells were harvested and lysed by French Press
and lysate was fractionated to S15 and P15 by
centrifugation (lanes 3 and 4). Lanes 1 and 2 rep-
resent uninduced control cells as indicated above.
S15 fraction was denatured with 6 M
guanidinium-HCl and subjected to Ni2+-NTA col-
umn. The buffer was changed to urea buffer and
the urea concentration was decreased by linear
gradient to 0.4 mM. Nsp1 was eluted with 167
mM imidazole in 0.4 M urea (lane 5). The pro-
teins were analyzed in 10% SDS-PAGE with
Coomassie blue staining.
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renature the protein by dialysis against 20
mM Tris, pH 8.0 or PBS failed. Furthermore,
several detergents (for example octyl-
glucoside, Triton X-100, thesit and chaps)
have also been used to solubilize Nsp1,
resulting in inactive enzyme and/or precipi-
tation (Ahola, unpublished; Karhi, unpub-
lished).
2.1.2. Expression of N-terminal fragment
of Nsp2 in E. coli (unpublished)
Since the N-terminal part of Nsp2 is rela-
tively small (N-Nsp2, aa 1-314, approx. 50
kDa) and has the predicted domains for RNA-
helicase- and NTPase-activities, an effort was
made to purify it for structural studies. N-
Nsp2 was produced in JM109 (DE3) cells as
described earlier (Rikkonen et al., 1994), and
was initially purified using IMAC-column
(Fig. 11A, lane 5). All attempts to concen-
trate the sample using membrane filtration
failed because of aggregation of the protein.
However, the elute from IMAC was further
purified by gel filtration chromatography
(Fig. 11B). In addition to being found in the
void volume, N-Nsp2 was also eluted at 22-
24 min fractions corresponding to an appar-
ent size of a monomer (40 kDa) in a concen-
tration of approx. 0.1 µg/µl. The concentra-
tion of N-Nsp2 after gel filtration indicated
that precipitation occurred within the column.
Again, any attempts to concentrate the GPC
purified product by membrane filtration or
dialysis led to irreversible precipitation of N-
Nsp2 (data not shown).
2.1.3. Expression of Nsp3 in E.coli
(unpublished)
To facilitate the purification process the
gene coding for Nsp3 was cloned into a
pHAT-vector, which includes a gene for a
histidine tag (Peränen et al., 1996; Hyvönen,
unpublished). The production of Nsp3 was
induced by 100 µM IPTG at 15°C, which was
determined to be the optimal expression con-
ditions for soluble Nsp3. The S15 fraction of
the cell lysate was subjected to IMAC (Ni2+-
NTA) and Nsp3 was eluted with 50 mM
imidazole (Fig. 12A). The Nsp3 containing
fractions were concentrated using membrane
filtration (PM30) at 10°C or at RT. The con-
centrate was further purified by gel filtration.
Figure 11. Expression and purification of his-tagged N-Nsp2 produced in E. coli. (A) The expression
of N-Nsp2 was induced by 50 µM IPTG and the cells were harvested and lysed after 6 hours incubation
at 24°C. P15 fraction (lane 4) was separated from S15 fraction (lane 3) which was applied to Ni2+-NTA
column. Lanes 1 and 2 represent S15 and P15 fractions from uninduced control cells. N-Nsp2 was
eluted with 40 mM imidazole (lane 5) and further purified by gelfiltration (lane 6). Proteins were
analyzed by 10% SDS-PAGE and Coomassie blue staining. (B) Gelfiltration of N-Nsp2 on a Superdex75-
column. N-Nsp2 eluted in the void volume and in the peak 22.2 min.
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Figure 12. Expression and purification of Nsp3. (A) His-tagged Nsp3 was expressed in E. coli by induc-
tion of 100 µM IPTG at 15°C. After harvesting and lysing the cell, the lysate was fractionated into P15 and
S15 (lanes 1 and 2). Nsp3 in S15 fraction was initially purified by Ni2+-NTA-column from which Nsp3 was
eluted with 50 mM imidazole (lane 3). Nsp3 was further purified by gel filtration (lanes 4-9). Gel filtration of
Nsp3 was performed on a Superdex 75 column (panels B-E). Nsp3 partially eluted in the void volume (peak
marked with *) but mostly at 19-21 min (peak 20.0 in panel B). Storage of the preparation overnight at 4°C
increased the amount of Nsp3 in the void volume (Panel C, peak marked with an asterisk). The peaks at 20
min (fraction in lane 7 in panel A) were collected, concentrated and applied again to gel filtration column
(D). The size of Nsp3 (90 kDa) was estimated according to molecular size standards (E).
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Initially, a small fraction of the Nsp3 eluted
in the void volume, though most of the pro-
tein eluted in the 19-21 min fraction (Fig.
12B). When the elute from the IMAC column
was stored overnight on ice, at 4°C or frozen
and thawed, the amount of Nsp3 in the void
volume increased (Fig. 12C). Nevertheless,
the peaks from several runs were collected
(Fraction in Fig. 12, lane 7), concentrated
(precipitated material was removed by cen-
trifugation) and subjected again to the gel fil-
tration column (Fig. 12D). The preparation
of Nsp3 was fairly pure containing only mi-
nor contaminants and had a protein concen-
tration of 1 µg/µl (Fig. 12A, lane 10). The
estimated molecular size of Nsp3 in gel fil-
tration was 90 kDa which indicated that Nsp3
was either in the mono or dimeric form (Fig.
12D and 12E). Nevertheless, storage, and
freezing and thawing of this material caused
precipitation of the Nsp3.
2.1.4. Expression of Nsp4 in Sf9 cells
(unpublished)
To further study the putative polymerase
activity of Nsp4, many efforts have been
made to purify this protein from E. coli for
structural analysis, with no success so far
(Russo unpublished; Pakula, unpublished;
Vihinen, unpublished; Ehsani, unpublished).
Here only the results concerning Nsp4 ex-
pression in baculovirus system are briefly pre-
sented. Sf9 cells were infected with
AcMNPV-Nsp4 at 50 PFU/cell and were har-
vested at 36, 40, 44 and 48 hours p.i. After
cell harvesting, lysing and fractionation,
nuclear, S15 and P15 fractions were analyzed
by SDS-PAGE, followed by Coomassie blue
staining (Fig. 13). At 36 hours p.i. the amount
of Nsp4 in the cells was undetectable, while
at 40 h p.i. Nsp4 was equally distributed in
the nuclei and P15 fractions, though only small
amounts were seen in the S15 fraction (Fig.
13, lanes 1-3). At 44 and 48 h p.i. most of the
protein was found in the nuclear fraction (Fig.
13, lanes 4-6). Next, the effect of inoculated
virus dose was studied as the cells were
infected with 100, 50, 5, 1 and 0.5 PFU/cell.
The analysis of cell fractions after 48 hours
p.i. demonstrated that the expression level
raised with increased PFU, but as soon as the
protein reached a visible level (detected by
Coomassie blue staining) it was distributed in
the nucleus and P15 fractions, and only small
amounts could be observed in the S15 frac-
tion (Fig. 13, lanes 7-9). With higher PFU/cell
Figure 13. Expression of Nsp4 in the baculovirus system (BSV). Sf9 cells were infected with
AcMNPV-Nsp4 with m.o.i. of 100 or 1 PFU/cell. The cells were harvested at 40 hours (lanes 1-3) and
at 48 hours (lanes 4-9) p.i., lysed by Dounce homogenizator and fractionated to the nucleus (N), P15
and S15. The proteins were analyzed by 10% SDS-PAGE followed by Coomassie blue staining.
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values, most of the protein appeared in the
nuclear fraction (data not shown). NaCl as well
as some detergents (thesit, octylclucoside,
CHAPS) were used to solubilize Nsp4 in P15
fractions. Since no enzymatic activity assay
for Nsp4 was available, only mild detergents
at low concentrations were tested in order to
maintain Nsp4 in its native conformation.
None of the treatments solubilized Nsp4, in-
stead it could be pelleted with a 15,000 x g
centrifugation (not shown). Attempts were also
made to purify Nsp4 from the nuclear fraction
(48 hours p.i.) by a sucrose gradient in the
presence and absence of 0.5% Triton X-100.
Most of the Nsp4 in the absence of detergent
floated to the border of 10 and 55% sucrose
(not shown). This buoyancy indicates that
Nsp4 is associated with membranes. This
association could be disrupted by treatment
with 0.5% triton X-100, though most of the
protein precipitated during this flotation
experiment. Also, sonication together with
treatment with various detergents was tried to
solubilize Nsp4 from the nuclear fraction.
However, in all the preparations, Nsp4
remained insoluble according to the general
definition of solubility (i.e., remains in the su-
pernatant after centrifugation at 100,000 x g,
1 h).
2.2. CHARACTERIZATION OF NSP1 AND NSP3
(IV-VI)
2.2.1. Critical residues for enzymatic
activities of Nsp1 (IV)
To localize amino acid residues essential
for the methyltransferase (MT) and guanylyl-
transferase (GT) activities, several deletions
and point mutations were made in Nsp1 (IV,
Fig. 1). BL21 cells were transformed with
pBATns1 and protein expression was induced
by IPTG. Expression levels similar to wt were
obtained, except in the case of Cys135Ala,
Cys142Ala and Asp180Ala, which all produced
lower amounts compared to wt. The MT and
GT activities of Nsp1 and its derivatives were
analyzed using S15 fractions (IV, table 1). The
mutations where the conserved aa were al-
tered destroyed or greatly reduced both MT
and GT activities, whereas mutations at less
conserved residues appeared to have no ef-
fect (IV, table 1). Two constructs: Cys81/83Ala
and Lys169Ala showed moderately reduced
MT activity, while Cys81/83Ala also appeared
to reduce GT activity. From the deletion con-
structs (aa 1-429, aa 1-478 and aa 1-515), only
the truncated construct aa 1-515 was active
in MT and GT analysis, whereas the larger
deletions caused loss of both activities. How-
ever, mutation His38Ala showed a moderate
increase in MT activity (160% compared to
the wt Nsp1), though it was totally deficient
in forming a covalent 7-methyl-Nsp1 com-
plex (IV, table 1).
To study the effect of palmitoylation on MT
and GT activities, some of the Nsp1 deriva-
tives were expressed in HeLa cells using the
vaccinia virus vTF7-3 expression system.
Expression levels were similar to that of wt,
except for mutants Cys135Ala and Cys142Ala,
which were expressed in lower amounts (data
not shown). The cells expressing Nsp1 and
its derivatives were labeled with [3H] palmi-
tate, immunoprecipitated with anti-Nsp1 an-
tiserum and analyzed by SDS-PAGE and au-
toradiography. All the derivatives were
palmitoylated to a level similar to that of wt
Nsp1 except for the mutant Leu19Glu (IV, Fig.
3). According to quantification by digital
imaging, the level of the palmitoylation in
this mutant was about 10% that of wt. It
appears that palmitoylation does not corre-
late with MT and GT activities, since this
mutant was totally deficient in both MT and
GT activities, whereas other MT and GT
deficient mutant constructs were palmitoy-
lated like wt.
To study the GT activity independently
from MT activity [14C]-labeled 7-methyl GTP
was synthesized. Contrary to all expectations
Nsp1 did not form a covalent complex with
this GTP derivative neither in the presence
nor in the absence of AdoMet, but required
the presence of AdoHcy for complex forma-
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tion (IV, Fig. 4). All the Nsp1 derivatives
which had both MT and GT activities, formed
complexes with 7-methyl GTP like wt. The
derivatives lacking either of the activities
(MT or GT) were not able to form the com-
plex. Finally, the different point mutations
were analyzed for their ability to bind
AdoMet and GTP. The binding properties
were analyzed by UV cross-linking in the
presence of EDTA which prevents the GT-
reaction. The derivatives which were defi-
cient in MT activity were also deficient in
binding AdoMet (IV, Fig. 6), though all the
derivatives were able to bind GTP (IV, Fig.
5).
2.2.2. Phosphorylation of Nsp3 (V and
VI)
In order to study the function of phospho-
rylation of Nsp3, the phosphorylation sites
were determined by electrospray and matrix-
assisted laser desorption/ionization mass
spectrometry, point mutational analysis, two-
dimensional (2D) phosphopeptide mapping,
and Edman sequencing. Nsp3 was produced
in HeLa cells by transfection, which supplied
sufficient amounts of the protein for this
study. According to phosphoamino acid
analysis, Nsp3 is phosphorylated on serine
and threonine residues in a ratio of approxi-
mately 2:1 in infected BHK cells (Peränen et
al., 1988). The relation of phosphorylated
serines to threonines turned out to be differ-
ent for Nsp3 produced in transfected HeLa
cells compared to SFV infected BHK cells,
i.e., the relation between phosphoserines and
phosphothreonines was approx. 6:1 (data not
shown). However, according to phospho-
peptide mapping the phosphorylation sites in
Nsp3 were the same regardless of the
expression type or cell line (V, Fig. 4).
2.2.2.1. Determination of phosphoryla-
tion sites (V)
The threonines at aa positions 344 and 345
were identified as phosphate acceptor sites
by point mutational analysis, when all 11
threonines in the C-terminal region of Nsp3
were mutated to alanines (VI, Fig. 2). These
two sites were further confirmed by mass
spectrometric (MS) analysis. For MS, Nsp3
was purified and cleaved into peptides as
described in the Materials and Methods
section (Fig. 8). A precursor ion scan of m/z
79 in the negative mode was done with
trypsin digested Nsp3, and revealed two ma-
jor peaks which could be tentatively identi-
fied as peptides Val308-Arg332 and Val308-
Lys323, both carrying one phosphate (V, Fig.
1B). Further analysis of these major peaks
by tandem MS identified the peptides as
Val308-Arg322 and Val308-Lys323 with one phos-
phate moiety, and the assignment of phos-
phorylation at Ser320. The phosphorylation of
Ser320 was also observed by point mutational
analysis followed by phosphopeptide map-
ping and Edman sequencing (V, Fig. 4 and
5A).
Fe3+-IMAC was used to enrich the phos-
phopeptides of Nsp3 digested with trypsin
and CNBr before MALDI mass analysis.
Masses revealed from MS were assigned to
peptides Lys324-Arg337 and Tyr324-Arg337 car-
rying from 1 up to 3 phosphates (V, Fig. 3A).
The signals corresponding to the phospho-
peptides disappeared after calf intestinal
alkaline phosphatase (CIAP) treatment pro-
viding further evidence for three phosphates
on this peptide (V, Fig. 3B). These peptides
were also identified by phosphopeptide map-
ping followed by Edman degradation, which
implicated the phosphorylation of serines 327
and 335 (V, Fig. 5B, 5D and 5E). Further-
more, according to phosphoamino acid analy-
sis, these peptides included only phospho-
serines supporting the result that threonines
328 and 329 are not phosphorylated (data not
shown).
Peptide Ser356-Met372 was putatively iden-
tified to be phosphorylated by MALDI-TOF
MS in the negative ion mode, which released
a series of peptide masses having a mass
difference of 80 Da (V, Fig. 3C). This peptide
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appeared to carry from 0 to 4 phosphates from
which up to three could be removed by phos-
phatase treatment (V, Fig. 3C and 3D). The
final identification of this peptide was
achieved by tandem MS identifying the pep-
tide being modified with an acrylamide ad-
duct (V, Fig. 2C). This peptide has up to four
possible phosphorylation sites, i.e, four
serines, which can, thus all be potentially
phosphorylated.
By ESI MS, ‘bump-like’ signals were re-
vealed and tentatively identified as a charge
series of peptide Gly338-Lys415. This peptide
appeared to contain 7 to 12 phosphates dis-
tributed over its 13 potential phosphorylation
sites. The same peptide was also most likely
seen in phosphopeptide mapping as a large
diffuse spot (V, Fig. 4B), but unfortunately,
it turned out to be impossible to sequence it
(V, Fig. 5C). This relatively long peptide (78
aa) has 11 aspartatic acid and 4 glutamic acid
residues, which can covalently attach to
membranes and result in an incorrect signal
upon Edman sequencing. Furthermore, this
peptide was the only one analyzed by
phosphopeptide mapping to contain both
phosphoserine and phosphothreonine (data
not shown).
2.2.2.2. Phosphorylation of Nsp3
derivatives (VI)
To study the phosphorylation of individual
amino acids, various point mutations in Nsp3
and a C-terminal deletion, N-Nsp3 (aa 1-328)
were made. The mutated derivatives were
expressed in HeLa cells by transfection, and
the Nsp3 proteins were labeled with [32P]
orthophosphate. The total phosphorylation
level of threonine double mutant (Thr344/
345Ala) was approximately 40% less than
that of wt Nsp3 as quantified with a phos-
phoimager (VI, Fig. 4). When either of the
threonines Thr344 or Thr345 were individually
mutated, a similar decrease in phosphoryla-
tion was observed (VI, Fig. 4). The mutation
Ser320Ala, which in mass spectrometric analy-
sis seemed to be a major serine phosphoryla-
tion site, also decreased the total phosphory-
lation of Nsp3 by 40-50% (VI, Fig. 4). How-
ever, when mutations Thr344,345Ala and
Ser320Ala were combined together, no further
decrease in phosphorylation was observed
(VI, Fig. 4, lane 5). The phosphorylation level
of N-Nsp3 was about 1% as compared to wt
(VI, Fig. 4). Mutation of the known phos-
phorylation sites located within N-Nsp3,
serine 320 to alanine did not greatly affect its
phosphorylation level (VI, Fig. 4). Further-
more, a small internal deletion of 26 amino
acids, Nsp326 (Nsp3343-368), reduced
Nsp3 phosphorylation by 90% (VI, Fig. 4).
These results suggest that the different phos-
phorylation sites may influence each other
in a rather complex manner, and therefore
phosphorylation of individual sites can not
be simply quantified based on point muta-
tional studies.
To study whether the full-length Nsp3 was
needed either to provide appropriate confor-
mation and/or kinase activity to phosphory-
late the serines/threonines in the region 320-
368, a N-terminal deletion construct (C-
Nsp3) was made (VI, Fig. 1).This peptide
could be labeled with [32P]orthophosphate
when expressed in HeLa cells by transfec-
tion (VI, Fig. 3). However, the phosphoryla-
tion level of the C-terminal peptide was about
30% of the full-length protein quantified by
double labeling with [35S]methionine/
cysteine and [32P]orthophosphate. This
difference may be due to an altered confor-
mation of the peptide or to the subcellular
localization of C-Nsp3, which differed from
the wt Nsp3 (VI, Fig. 5). The possibility of
Nsp3 autophosphorylation was studied by co-
transfecting wt Nsp3 with the C-terminal
peptide, but no increase in the phosphoryla-
tion level of C-Nsp3 was detected (VI, Fig.
3). Since it is unlikely that the non-conserved
C-terminal region could posess any kinase
activity, these results suggest that the phos-
phorylation of C-Nsp3 and wt Nsp3 is cata-
lyzed by cellular kinases.
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2.2.2.3. Elimination of phosphorylation
sites (V and VI)
Based on phosphopeptide mapping fol-
lowed by Edman degradation as well as mass
spectrometric and point mutational analysis
of Nsp3, the phosphorylation sites of Nsp3
were determined as serines 320, 327, 332, 335
and 12 Ser/Thr in the peptide Gly338-Lys415.
Two non-phosphorylated mutants were gen-
erated. The first had a deletion of 50 aa
(Nsp3319-368) that removed the whole
potential region of phosphorylation
(Nsp350). The second construct had a 26
aa deletion (343-368) together with serines
320, 327, 332 and 335 being mutated to ala-
nines, and designed as Nsp326+4S4A.
This later construct maintained highly con-
served residues such as Tyr324. Although these
constructs were expressed in HeLa cells at
amounts similar to wt Nsp3, no [32P]-incor-
poration could be detected with these Nsp3
derivatives (V, Fig. 6 and unpublished).
Assuming that the deletions did not affect the
overall confirmation of Nsp3, it appears that
Thr378 was not modified by phosphorylation.
Both mutants were also cloned into the
genome of SFV and the deficiency of phos-
phorylation was confirmed by double label-
ing (VI, Fig. 6 and unpublished).
2.2.2.4. Effect of phosphorylation on
membrane association (VI)
To study the effects of phosphorylation of
Nsp3 on its membrane association, a C-ter-
minal deletion mutant (aa 1-328) was con-
structed (VI, Fig. 1). Two putative phospho-
rylation sites (Ser320 and Ser327) remained in
this truncated Nsp3, and it was phosphory-
lated at one percent of wt (VI, Fig. 3). How-
ever, according to flotation assays this deriva-
tive has an affinity to membranes similar to
wt Nsp3, and like Nsp3 this attachment could
be dissociated by 1 M NaCl (VI, Fig. 5). This
result was further confirmed by indirect im-
munofluorescence studies when non-phos-
phorylated derivatives, expressed by trans-
fection or in SFV infection, were found in
similar vacuole like structures as wt Nsp3
(VI, Fig. 5 and unpublished).
2.2.2.5. Phosphorylation deficient Nsp3
in the context of SFV (VI)
To study the effect of phosphorylation on
virus replication, Nsp3 phosphorylation de-
ficient mutants were placed in the SFV ge-
nome (SFV Nsp350 and SFV Nsp326+
4S4A), and mutant viruses were grown in
BHK, Vero and NIH cells. All the mutants
were able to propagate in these cell lines and
showed titers close to those of the wt SFV
(VI, Fig. 7A and unpublished). This indicated
that Nsp3 phosphorylation was not required
for SFV replication in these cell lines.
The effects of these Nsp3 mutants on patho-
genicity in mice were also investigated. At
three weeks post-inoculation, 20% and 66%
of the mice infected with doses of 106 PFU/
mouse SFV Nsp326+4S4A and wt SFV,
respectively, were killed (unpublished). With
higher doses (107 PFU/mouse) no mice sur-
vived the infection by wt SFV, whereas 66%
of the mice infected with SFV Nsp326+
4S4A were still alive at three weeks. Viral
doses up to 107 PFU/mouse of SFV Nsp350
were avirulent for adult mice (VI).
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DISCUSSION
1. HSP150 AS A CARRIER FOR PROTEIN
PRODUCTION
The ability of Hsp150 to confer secretion
competence to heterologous proteins has been
first studied with ß-lactamase, which is a
periplasmic protein of E. coli (Simonen et al.,
1994). ß-lactamase was chosen as the reporter
protein, since it is not secreted in yeast with
its own signal peptide and its conformation
is easy to monitor by an enzymatic assay
(Roggenkamp et al., 1985; Carwright et al.,
1994). When ß-lactamase is fused to C-ter-
minus of Hsp150, the protein is secreted to
the medium but is enzymatically inactive.
Fusion of ß-lactamase to subunit I results in
a fusion protein with poor activity and secre-
tion competence (Simonen et al., 1994;
Holkeri and Makarow, 1998). The fusion pro-
tein that is enzymatically active and secreted
efficiently to the growth medium, is the con-
struct in which ß-lactamase is fused to the
repetitive region of Hsp150 (Simonen et al.,
1994). Moreover, the first four repeats of sub-
unit II have been shown to be sufficient to
confer secretion competence although slower
than the carrier with 11 repeats (Suntio et al.,
1999).
The ability of Hsp150 to confer secretion
competence was further evaluated using the
extracellular domain of a mammalian trans-
membrane protein, rat nerve growth factor
receptor (NGFRe) (II). Since NGFRe (223 aa)
has 12 disulfide bridges, it was thought to
offer a challenge for the folding machinery
of the yeast ER. When NGFRe was fused to
the signal peptide of yeast invertase, it was
translocated into the ER, but unable to exit
the ER. NGFRe was degraded in the ER
lumen by a currently unknown mechanism
(Holkeri et al., 1998). However, when NGFRe
was fused to Hsp150, the fusion protein was
secreted to the growth medium and acquired
a conformation capable of binding its natu-
ral ligand, NGF. Hsp150-NGFRe could also
inhibit the cross-linking of NGF to the au-
thentic NGFR. However, only approximately
half of the binding could be inhibited by the
fusion protein, which could possibly be ex-
plained by its linkage to the Hsp150 carrier.
Hsp150-NGFRe was secreted to the medium
at a concentration of approximately 10 milli-
grams per liter (II). A similar level of expres-
sion (10-15 mg/l) was obtained when tick
anticoagulant peptide was produced in S.
cerevisiae utilizing the pre-pro-region of -
factor (Cook et al., 1998).
Subunit II of Hsp150 was found to be O-
glycosylated with di-, tri-, tetra- and penta-
mannosides in a ratio of 4:1:1:1 (I). Based
on mass spectrometric analysis 65 of the po-
tential 85 Ser/Thr-residues in subunit II were
glycosylated, as well as most, if not all of the
potential 21 Ser/Thr residues in subunit I
(Suntio et al., 1999). When fused to Hsp150,
NGFRe was N-glycosylated at its one poten-
tial site, but not glycosylated at any of its 41
potential O-glycosylation sites, whereas the
carrier portion was heavily O-glycosylated
(III). Moreover, the distortion of protein fold-
ing caused by preventing disulfide bridge
formation did not affect the O-glycosylation
of the fusion protein but enhanced N-
glycosylation of NGFRe portion. Thus, it ap-
pears that the O-glycosylation machinery of
yeast is highly selective.
Yeast BiP/Kar2p, a member of Hsp70 chap-
erones, is thought to assist the translocation
of de novo synthesized proteins across the
ER membrane as well as conformational
maturation after translocation (Gething and
Sambrook, 1992; Simons et al., 1995; Jämsä
et al., 1994). It has been shown that,
Hsp150-ß-lactamase requires BiP/Kar2p
for both translocation and maturation, even
though it has only one disulfide bridge
(Holkeri et al., 1998). However, the folding
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of NGFRe is assumed to occur domain by
domain during the on going translocation
(Netzer and Hartl, 1997). Like TGFR, the
structure is more likely to be determined by
hydrogen bond formation rather than disul-
fides (Banner et al., 1993). Indeed, when the
conformation of NGFRe is distorted by DTT,
only mild conformation changes occur and
the proteins are rapidly secreted after removal
of DTT. Thus, even if BiP/Kar2p is required
for the translocation of Hsp150-NGFRe, the
conformational maturation occurs in the ab-
sence of the chaperone (Holkeri et al., 1998).
The numerous disulfide bridges of NGFRe
seem to have only a minor role in the folding
process making this molecule relatively easy
to be secreted.
Hsp150, truncated Hsp150, and Hsp150-
NGFRe were purified from the growth me-
dium by membrane filtration, ion exchange,
and gel filtration chromatography, and in
some cases using reserved phase chromatog-
raphy. The purity was verified by N-terminal
sequencing. All of the proteins were purified
to homogeneity since no other signal was
detectable (II). Probably due to the high level
of O-glycosylation, these proteins were hy-
drophilic which made the purification pro-
cess relatively easy. CD and NMR spectros-
copy revealed that the repetitive region of the
carrier protein lacked secondary structure,
and ß-sheet occurred in the C-terminal part
of subunit II and/or in subunit I. It is pos-
sible, that the lack of a secondary structure
in this carrier protein promotes the fusion
partner to acquire proper conformation e.g.,
by attracting chaperones.
2. EXPRESSION AND CHARACTERIZATION
OF SFV NSPS
2.1. EXPRESSION AND PURIFICATION OF NSPS
One of the main reasons for expressing and
purifying the Nsps was to obtain enough
protein for crystallization studies. For this
purpose two essential requirements are that
the protein is extremely pure, and it is dis-
solved in an aqueous medium at relatively
high concentrations (5-20 mg/ml) (Durbin
and Feher et al., 1996). Even crystals can
occasionally be grown from impure samples,
the size and quality of the crystals improve
as the purity of the protein increases (Ollis
and White, 1990). Proteins with hydrophobic
regions such as membrane proteins are prob-
lematic, since they easily form aggregates and
oligomers. In SFV infected cells, all the Ns-
proteins are associated with cellular mem-
branes (Ahola et al., 1999). For example,
Nsp1 is attached to membranes by at least
two different mechanisms. Firstly, it is
palmitoylated at cysteine residues 418-420,
which probably aids in membrane associa-
tion (Laakkonen et al., 1996). Secondly, it has
a short segment (aa 245-264) which appear
to be involved with membranes consisting of
anionic phospholipids such as phosphatidyl-
serines (Ahola et al., 1999). When Nsp1 was
expressed with the baculovirus system, it was
mainly concentrated in the P15 fraction
(Laakkonen et al., 1994). After solubilization
of the membranes by DOC, the protein re-
mained enzymatically active, but the molecu-
lar size of Nsp1 aggregates were still over
300 kDa. The methyltransferase (MT) activ-
ity of Nsp1 produced in E. coli was mainly
recovered in the S15 fraction, but the protein
was precipitated in a sucrose gradient centri-
fuged at 100,000 x g (Laakkonen et al., 1994).
It has been suggested that both enzymatic
activities (methyltransferase and guanylyl-
transferase) of Nsp1 are dependent on the
membrane attachment (Ahola et al., 1999).
When a protein is to be refolded from ag-
gregates i.e., inclusion bodies, it must be solu-
bilized prior to the refolding into its native
conformation can occur. The refolding step
is complex and depends greatly on the rena-
turing conditions, such as, pH, rates of dialy-
sis, protein concentration and redox condi-
tions (Valax and Georgiou, 1993). In addi-
tion, the concentration of the protein should
be fairly low (10-100 µg/ml) for proper fold-
ing (Maachupalli-Reddy et al., 1997). Thus,
Discussion
51
usually after the refolding step the protein
must be concentrated. In the case of Nsp1,
preliminary attempts to renature it after puri-
fication under denaturing conditions were not
successful, and no enzymatically active pro-
tein could be obtained. To further investigate
the potential of this approach, the following
parameters should be varied: protein concen-
tration, temperature, pH and dialysis buffers,
so that the optimal conditions for Nsp1 rena-
turation could be found. In a related study, it
has been reported that applying high hydro-
static pressure (1-2 kbar) to suspensions con-
taining aggregates of recombinant human
growth hormone, lysozyme or ß-lactamase
resulted in properly folded proteins (St. John
et al., 1999).
In addition to Nsp1, fractions of Nsp2,
Nsp3 and Nsp4 are tightly bound to the cyto-
plasmic membranes of SFV infected cells
(Ahola et al., 1999). The membrane associa-
tion of Nsp3, when expressed alone by trans-
fection, did not appear to be very tight since
it could be released from the membranes with
salt treatment (VI). A fraction of all Nsps can
be found in vesicular structures in infected
and transfected cells (Kujala et al., 2001). All
of these proteins have hydrophobic regions
in their amino acid sequences. For example,
Nsp3 has a potential segment for membrane
attachment between aa 99-116, which in con-
tact with membranes could form a amphi-
philic helix (Fig. 14). This region is highly
conserved among alphaviruses, and it can be
found also in rubella and hepatitis E viruses.
These hydrophobic segments may partly ex-
plain the characteristic tendency of Nsps to
from aggregates. The removal of the hydro-
phobic C-terminal region (55 aa) from hepa-
titis C NS5B protein allowed its purification
from E. coli, and structural characterization
of its active RNA-dependent RNA poly-
merase unit by crystallization studies
(Bressanelli et al., 1999). The 55 aa deletion
did not appear to affect its polymerase activ-
ity, and a further deletion of 21 aa in a hydro-
phobic region seemed to increase its RNA
polymerase activity (Bressanelli et al., 1999;
Tomei et al., 2000). Structural studies of the
catalytic subunit of Hepatitis-C, poliovirus
and two retrovirus replicase proteins suggest
similar structures of the catalytic unit that
appear to be shared in all of these viruses
(Hansen et al., 1997; Jäger and Pata, 1999;
Bressanelli et al., 1999). It remains to be seen
whether the structural features of the cata-
lytic subunit of Hepatitis-C, poliovirus and
retrovirus are also conserved within alpha-
viruses.
The insolubility problem is difficult to over-
come and varies from case to case. For ex-
ample, some proteins such as immunoglobu-
lins need high ionic strength to remain soluble
(Harris et al., 1995). In case of Nsps, salt
concentration had only small effects on solu-
bility. Also pH is crucial for the purification
process, and the more the pH of crystalliza-
tion differs from the isoelectric pH, the higher
is the protein net charge and its solubility.
However, calculated isoelectric pH values are
only theoretical since some posttranslational
modifications can greatly affect the final net
charge. Detergents can play a crucial role in
the crystallization of membrane proteins
Figure 14. An amphiphilic helical wheel of Nsp3
aa 99-116. The amino acid residues of other
alphavirus Nsp3s, as well as hepatitis E in brack-
ets, are marked.     = hydrophobic residue.
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(Marston and Hartley, 1990; Thomas and
McNamee, 1990; Hjelmeland, 1990). The
detergents used to crystallize membrane
proteins are generally simple nonionic or
zwitterionic compounds. At detergent con-
centrations below critical micelle concentra-
tions (CMC) most membrane proteins are not
very soluble and may form two dimensional
crystals (Thomas and McNamee, 1990). 3D
crystals are often found close to the condi-
tion where phase separation occurs. The de-
tergent to protein ratio may be a critical
parameter for successful crystallization of
membrane proteins. Many proteins appear to
have well defined detergent-to-protein ratios
for optimal solubilization. For most deter-
gents with high CMC (>1%), protein solubi-
lization occurs at or near the CMC. Even
though some detergents were utilized to solu-
bilize Nsp1, no conditions were found suit-
able for purification (Ahola, personal com-
munication). Furthermore, disruption of
essential protein-lipid or protein-protein in-
teractions by the detergent might lead to in-
activation or denaturation. Purification of
proteins with unknown functions limit the
choices of detergents and concentrations in
which they can be used.
2.2. GT AND MT ACTIVITIES OF NSP1
Nsp1 has been found to catalyze two reac-
tions in the capping of viral mRNA, i.e.,
firstly, the transfer of a methyl group from
AdoMet and secondly, the formation of a
covalent complex, m7GMP-Nsp1 (IV; Ahola
and Kääriäinen, 1995). The structural region
and amino acid residues involved in these
activities were elucidated with point muta-
tional analysis (IV). These studies revealed
that a mutation at His38 destroyed GT activ-
ity, which made this residue a putative bind-
ing site for m7GMP. SFV His38 is conserved
among the alphavirus superfamily, and a
mutation of a respective residue in SIN Nsp1
resulted in a noninfectious viral RNA
(Rozanov et al., 1992; Niesters and Strauss,
1990). Structural studies of five AdoMet-de-
pendent MTs suggested similarities in
AdoMet-binding sites, which are consistent
with an antiparallel ß-sheet flanked by alpha-
helixes (Schluckebier et al., 1995). The sec-
ondary structure predictions of Nsp1 showed
that it shares similarities with the structures
of cellular MTs especially in its N-terminal
domain (IV). Also the G-loop (UU-Asp-
UoooXo; U=large hydrophobic residue,
o=Gly/Ala/Ser, X=any residue) which is
characteristic for MTs can also be found in
the Nsp1 sequence (Koonin et al., 1995;
Ingrosso et al., 1989). Mutational analysis
indicated that residues Asp64 and Asp90 are
required for AdoMet binding activity. Fur-
thermore, Asp64 is conserved within the
alphavirus-like superfamily and Asp90 may
represent the conserved acidic residue
involved in binding hydroxyl groups in
AdoMet (Djordjevic and Stock, 1997). Cys142
was also required for the binding of AdoMet,
whereas the residues Arg93, Cys135 and Tyr249
were essential for binding of AdoMet and
required for MT activity (IV). The conserved
residues His39, Asp91, Arg94 and Tyr249 were
also mutated in SIN Nsp1 and found to be
critical for MT activity as well as for virus
replication (Wang et al., 1995).
2.3. PHOSPHORYLATION OF NSP3
Using different analytical methods, i.e.,
mass spectrometry (MALDI TOF MS and
ESI MS) point mutational analysis, phospho-
peptide mapping and Edman sequencing, it
was possible to identify major phosphoryla-
tion sites in Nsp3. The phosphorylation re-
gion was located within 48 aa, Ser320-Ser368,
where 12 serines and 4 threonines could be
phosphorylated. No direct data was obtained
regarding the phosphorylation state of Thr378,
but assuming that a 26 aa internal deletion
together with 4 point mutations in Nsp326+
4S  4A did not affect the accessibility of
Thr378 to kinase(s) by causing conformational
changes, it appears that in Nsp3, Thr378 is not

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modified by phosphorylation (V). The phos-
phorylation of Nsp3 was heterogeneous as
suggested by the finding that some of the
phosphorylation sites were also detected in
unphosphorylated state by MS. Within this
area, mutation of one or more serines/thre-
onines affected the phosphorylation of the
other residues, i.e., the phosphorylation of
some residues was dependent on the phos-
phorylation of other residues. Furthermore,
the ratio of phosphorylated serines and thre-
onines in Nsp3 varied according to the
method and cell line, being 6:1 (V) and 2:1
(Peränen et al., 1988), in transfected HeLa
cells and SFV infected BHK cells, respec-
tively. However, phosphopeptide mapping
revealed similar patterns for Nsp3 from both
of these expression types, which indicates that
in spite of the ratio difference, the sites of
phosphorylation were the same. Difference
in the ratio of phosphorylated serines to thre-
onines could be due to the different cell types
used, differences in the cellular kinases in-
volved, and/or the interacting of host factors
with the viral proteins.
Even though Ser320 appears to be a major
phosphorylation site in transfected HeLa cells
and is in the conserved region of SFV Nsp3,
it is not conserved among all alphaviruses.
In general, the common features of the C-
terminal domains of alphavirus Nps3s are
negatively charged regions which are serine
and threonine rich with short proline rich
domains. The C-terminal region of SIN Nsp3
is longer (34 aa) and has 19 Ser/Thr residues
more compared to SFV Nsp3. No systematic
phosphorylation site analysis of SIN Nsp3
have been made, but a C-terminal deletion
has been observed to dramatically reduce
phosphorylation (LaStarza et al., 1994a). In-
terestingly, the C-terminal region of SIN
Nsp3 has two separate domains rich in serines
and threonines, both of which could be phos-
phorylated resulting in different forms of SIN
Nsp3.
2.3.1. Determination of phosphorylation
sites
Nsp3 was a challenging molecule for phos-
phorylation analysis since it has 39 serine and
35 threonine residues, all potential phospho-
rylation sites. Also, the resistance of Nsp3 to
trypsin digestion together with one large tryp-
tic peptide (78 aa) make it difficult to ana-
lyze. This large peptide was identified as a
phosphopeptide by precursor ion scanning,
and it contained from 7 to 12 phosphates over
its 13 potential sites. Unfortunately, no exact
phosphorylation sites could be determined
due to its large size and extensive phospho-
rylation. In addition, its large size and high
number of acidic residues (15 Glu/Asp) pre-
vented this peptide to be analyzed by Edman
sequencing as well.
MS is a very sensitive method but ex-
tremely pure peptide samples are required for
analysis. In addition, the phosphopeptide
must have a molecular weight of more than
600 Da in order not to be masked by signals
coming from the matrix material itself. Large
peptides or peptides containing multiple
phosphates are not likely to produce infor-
mative fragmentation patterns, which would
allow for site specific assignment of phos-
phorylation over the sequence. Data from the
MALDI/CIAP experiments, point mutational
analyses or Edman sequencing alone would
not have been sufficient for unequivocal iden-
tification of the phosphorylated residues of
Nsp3 (V). Several independent methods were
needed to localize phosphorylated residues,
since any of these methods used alone would
have resulted in only partial information
about the phosphorylation sites.
2.3.2. Kinases
The C-terminal region of Nsp3 (aa 312-
482) was phosphorylated when expressed
alone, although at reduced levels as compared
to the wt Nsp3 (VI). This reduced phospho-
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rylation may reflect conformational changes
in the polypeptide that lead to differential
kinase recognition. Co-expression with the
wt Nsp3 did not increase the phosphoryla-
tion of the C-terminal peptide, indicating that
Nsp3 is unlikely be a kinase by itself. An al-
ternative explanation for the diminished
phosphorylation of C-Nsp3 is offered by the
fact that it is localized in the cell cytoplasm,
whereas the wt Nsp3 was associated with
vesicular structures. Thus, C-Nsp3 might not
be equally accessible to membrane-associated
kinases, which may play a role in phospho-
rylating the wt Nsp3. The phosphorylation
of Nsp3 was, however, not required for its
peripheral membrane association. In addition,
Nsp3 lacks any catalytic domains present in
almost all eukaryotic kinases determined by
sequence comparisons. These results indicate
that the phosphorylation of Nsp3 is most
likely to be mediated by kinase(s) of cellular
origin.
SIN Nsp3 has been suggested to be phos-
phorylated by casein kinase II (CK II) (Li et
al., 1990). Most of the phosphorylation sites
identified in this study are putative phospho-
rylation sites for CKII evincing that CKII
could be a kinase involved in phosphoryla-
tion of SFV Nsp3. Serines 327 and 367 have
a preferred recognition sequence, [Ser/Thr]-
x-x-[Asp/Glu], for CKII and most of the other
phosphorylation sites in Nsp3 are also puta-
tive sites for CKII assuming that the adja-
cent Ser/Thr-sites have been already phos-
phorylated by additional kinases (Kennelly
and Krebs, 1991). However, Ser320 and Ser335
do not have a consensus sequence for CKII,
but instead have a recognition sequence for
protein kinase C, [Ser/Thr]-x-[Arg/Lys], as
does Ser332 (Kennelly and Krebs, 1991). SFV
Nsp3 Ser320 is also in a consensus site for
p34cdc2-kinase, which in turn is phosphory-
lated by CKII (Russo et al., 1992b). NS5A,
the phosphoprotein of hepatitis C and bovine
viral diarrhea virus as well as NS5 of yellow
fever virus (all members of family
Flaviviridae) are suggested to be phospho-
rylated by a kinase or kinases from the
CMGC group of serine/threonine kinases
which includes e.g., CKII and proline-di-
rected kinases (Reed et al., 1997; Reed et al.,
1998). Among negative strand RNA viruses,
the phosphoprotein P of measles, rabies, ve-
sicular stomatis and Sendai virus have been
reported to be phosphorylated by two differ-
ent kinases (Gupta et al., 2000; Barik and
Banerjee, 1992; Huntley et al., 1997; Byrappa
et al., 1996).
2.3.3. Effects on the virus cycle and
neurovirulence
The identified phosphorylation sites of SFV
Nsp3 were eliminated by a deletion or by a
deletion combined with point mutations re-
sulting in Nsp3 phosphorylation defective
mutant viruses. Surprisingly, these viruses
showed only minor differences in replication
compared to the wt SFV, in BHK, Vero and
NIH cells. Thus, phosphorylation of SFV
Nsp3 is not essential for virus replication in
the cell lines tested. Similarly, a large dele-
tion in the C-terminal region of SIN Nsp3
did not affect its plaque forming ability in
mammalian cells (LaStarza et al., 1994a).
However, this derivative showed a poor
plaque formation in mosquito cells. Thus,
even though phosphorylation of SFV Nsp3
is not essential in BHK, Vero nor NIH cells,
it could play an important role in replication
in other cell lines such as insect cells. The
ultimate function of phosphorylation remains
to be resolved, as well as the function of Nsp3
in the SFV infection cycle. Among negative-
strand RNA viruses, phosphoproteins of
paramyxoviruses and rhabdoviruses act as
chaperons for nucleoprotein, preventing its
polymerization and nonspecific binding to
cellular RNA (Tarbouriech et al., 2000;
Curran et al., 1995). The phosphorylation
state of P proteins have been reported to be
essential for efficient transcription of viral
polymerase among negative-strand RNA vi-
ruses (Mazumder and Barik, 1994; Barik and
Banerjee, 1992).
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The pathogenesis of Nsp3 phosphorylation
defective viruses were studied in mice.
Groups of five mice were infected intraperi-
toneally with 106 and 107 PFU/mouse of the
wt and mutant viruses. The phosphorylation
defective mutant SFV Nsp326+4S  4A
showed a significant reduction in pathoge-
nicity whereas SFV Nsp350 in the same
experiment turned out to be apathogenic.
Since both of these constructs were Nsp3
phosphorylation defective the apathogenic
feature of latter mutant virus may be a result
of the deletion of some conserved residues
in region 319-342. Furthermore, the route of
infection (i.e., intraperitoneal or intranasal
route) may also contribute to the resulting
pathogenicity (Atkins et al., 1999).
SFV strain A7(74) has been derived from
an apathogenic SFV strain A7 by further se-
lection for avirulence (Bradish et al., 1971).
In the neurons of adult mice A7(74) is un-
able to form virions and all the infected mice
remained asymptomatic (Tuittila et al., 2000).
There are multiple mutations in A7(74) com-
pared to the wt SFV4 strain, which in the re-
gion of Nsp3 include 9 single aa mutations,
7 aa deletion and an opal termination codon
between Nsp3 and Nsp4. The 7 aa deletion
(Gly-Ile-Ala-Asp-Leu-Ala-Ala) did not con-
fer the attenuation of SFV4 virulence whereas
opal and an other aa mutation in the region
of Nsp3 reconstituted a virulent virus (Tuittila
et al., 2000). Nevertheless, none of the mu-
tated aa were in the deleted region of
Nsp350 suggesting that in addition to the
opal codon, also the non-conserved C-termi-
nal region, including the phosphorylation
sites, is significant in the regulation of virus
pathogenesis in mice. Thus, neither of these
virus strains are capable of the rapid spread
and replication in the central nervous system
that is required for neurovirulence.
3. CONCLUSIONS AND FUTURE ASPECTS
The power of utilizing molecular engineer-
ing to produce recombinant proteins for vari-
ous purposes has revolutionized many areas
in biotechnology. In this study, modern mo-
lecular techniques were applied to produce
and purify fungal and viral recombinant pro-
teins in a variety of production systems.
Structural studies of Hsp150 revealed the
first conformation information of a yeast car-
rier peptide. The extended structure of this
carrier may allow the attached foreign pro-
teins to be freely folded into their native con-
formations. We showed that the Hsp150
carrier is able to secrete NGFRe in a ligand
binding form, but further work must be done
to improve the recombinant protein produc-
tion and secretion efficiencies. The possible
introduction of the Hsp150 carrier into other
yeast strains (e.g., Pichia pastoris) might be
useful in the attempts to increase of the pro-
duction level.
All efforts to date to purify individually
expressed Nsps amounts sufficient enough
for structural studies have been unsuccess-
ful. The conditions applied in this study for
expression of Nsps in E. coli or by the
baculovirus system, differ dramatically from
a natural SFV infection. During SFV infec-
tion Nsps are produced in very low amounts,
most of them are membrane associated, and
they are folded from a large, autoprote-
olytically cleaved, polyprotein precursor. The
enhanced recombinant protein expression in
bacteria and insect cells led to undesired ag-
gregation of the individually produced Nsps.
However, it might still be possible to find
new, sophisticated systems to facilitate the
expression and purification of Nsps for their
crystallization. Such system might utilize
polyprotein expression in eukaryotic cell lines
to produce Nsps, in their native conforma-
tions and in quantities high enough to enable
their structural studies.
This study also reports the first results
regarding the phosphorylation sites of an
alphavirus Nsp. The techniques used to map
the phosphorylated aminoacid residues in
Nsp3 were a combination of several differ-
ent methods, and the same analytical strate-

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gies could be applied to other phosphopro-
teins. The article V as well as the phosphory-
lation sites of SFV Nsp3 has been entered in
the internet database of Protein Research
Foundation (http://www.prf.or.jp/en/dbi.html
under accession number 2620611), which is
collecting the information related to amino
acids, peptides and proteins. The localization
of the Nsp3 phosphorylation sites provided
the opportunity to study the effects of elimi-
nation of Nsp3 phosphorylation, both bio-
chemically and in the context of SFV infec-
tion. The Nsp3 phosphorylation defective
mutant virus was able to replicate in cell
culture to titers similar to that of wt SFV, but
appeared to be avirulent for adult mice. This
observation can be utilized in generating non-
pathogenic SFV-vector for protein expression
in a number of different higher eukaryotic
systems. In addition, future studies could
investigate the potential phosphoesterase
activity at the N-terminal portion of Nsp3. A
careful characterization might add knowledge
to the function(s) of Nsp3 phosphorylation,
as well as the function of Nsp3 in the SFV
infection cycle.
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